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Abstract 
The basis of supramolecular chemistry is a detailed knowledge of fundamental molecular 
properties and non-covalent interactions, which is dedicated to the preparation of novel 
structures as functional materials. Here we discuss the design and synthesis of such new 
molecular self-assemblies. Based on the structures and properties of these molecules, this 
dissertation describes the two types of supramolecular structures in two different chapters. 
Chapter 1 deals with the design, preparation, characterization and applications of 
chiral, bio-degradable, guest-specific and environment-friendly nanoporous crystalline 
dipeptides. In the hydrogen-bonded networks, dipeptides with hydrophobic L-amino acid 
residues are known to form pores of different diameters, ranging from 3-10 Å. The 
hydrophobic bulk and orientations of the side chains of these dipeptides provide further scope 
for structure-based modifications to fine-tune their pore dimensions. Thus, towards the 
liberation of space occupied by bulky hydrophobic terminals of the amino acid side chains 
from the periphery of channels, a series of dipeptides from non-proteinogenic and 
proteinogenic amino acids have been synthesized, crystallized and analyzed by single crystal 
X-ray diffraction methods. The majority of these dipeptides were obtained as porous 
structures. As nanoporous materials, a few of these dipeptides were studied for CO2 and 
methane gas absorption and selectivity. 
Chapter 2 demonstrates the supramolecular synthesis of charge-assisted complexes 
from binary acid-base components. The well-directed hydrogen bond formation between acids 
and bases is a very useful tool in designing new supramolecular assemblies. Here we pursued 
an approach to use 1,5,7 triazabicyclo[4.4.0]-dec-5-ene, a guanidine derivative, with di- or 
monocarboxylic acids to generate guanidinium-carboxylate complexes. These molecular 
structures were designed to explore the effects of limited hydrogen-bond forming ability of 
guanidinium moiety and carboxylate group, and to check the propensity of guanidinuim-
carboxylate complexes for the inclusion of guest molecules, for instance the water molecules. 
In fact, these complexes in crystals have interacted with the water molecules or carboxyl 
groups in the absence of any other potential donors and formed different water networks and 
1D molecular pattern, which as organic materials may find various future applications as 
proton conductors, selective ion channels and gelators etc. 
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Introduction: Supramolecular Chemistry 
Supramolecular chemistry is a branch of chemistry devoted to the study of systematic 
aggregation of two or more chemical moieties through non-covalent forces between them, 
covering their functions and structure properties. In other words, as stated by Jean Marie Lehn 
the supramolecular chemistry is ‘‘chemistry beyond the molecule’’.1-4 This means that a better 
insight into the implicit properties of the covalently bonded atoms at the molecular level is 
essential in supramolecular chemistry to understand the intermolecular interactions between 
complementary molecules,5 such as the hydrogen-bonded networks formation between the 
carboxylic acid groups (Fig. 1). 
 
Figure 1: The difference between covalent and supramolecular syntheses.   
 
Natural Processes and Supramolecular Chemistry  
In nature, supramolecular chemistry is ubiquitous.4,6 Earlier, to facilitate the preliminary 
understanding of biological transformations through binding of enzyme and substrate, the 
concept ‘lock-and-key’ was proposed by Emil Fisher (1894).7,8 Later with the initial essence 
of intermolecular interactions, the adducts of receptors and substrates were referred as 
‘supermolecules’ (1937).9,1 In the late 20th century it was evident from breakthrough 
discoveries that the weak intermolecular interactions are the responsible forces for self-
organization or spatial arrangements of macromolecules and extra- or intracellular bio-
chemical modifications in the biological systems.10-12 The well known examples of such 
natural self-assemblies are the pairing between complementary DNA bases i. e. ; Adenine 
(A)-Thymine (T); and Guanine (G)-Cytosine (C), (Fig. 2) to form a double-stranded DNA 
(Fig. 2),13 ion transportation through the transmembrane channels,14,15 DNA-histone protein 
complex formation,16,17 RNA-protein recognition,18-20 enzymatic catalysis,21,22 protein-protein 
interactions,23 arginine recognition,24 stability/folding of proteins/enzymes by hydration,25,26 
folding of peptide chain into an α-helix or a β-sheet27 and further into a functional domain, for 
example, myoglobin, a metalloprotein in all vertebrates (Fig. 3). 
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Figure 2: H-bonded DNA base pairs and a double stranded DNA. 
 
          
               myoglobin  
Figure 3: The H-bonding-assisted folding of polypeptide chains into secondary protein structures i. e. 
α-helix and β-sheets. The hydrogen bonds are shown with the red-colored broken lines. Myoglobin, a 
functional hemeprotein, illustration is adapted from reference.28 
These observations of precise attraction and binding through non-covalent interactions 
in nature offered the initial ideas not only to develop the ion-specific artificial macrocyclic 
receptors29,30 and host-guest complexes,31 but it has also inspired to design the tactics to 
prepare nanoscale assemblies from the small peptides32-39 and from various complementary 
organic building blocks40,41 as materials.4 
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Specific Intermolecular Interactions and Crystal Engineering  
Self-assembly of molecules, alongside the strong hydrogen bonds (N–H···O, N–H···N, 
N···H–O, O–H···O, S–H···O and  S–H···N etc.) also includes weaker electrostatic or 
coulombic forces (ion-ion, ion-dipole, and dipole-dipole),42,43 co-ordinate interactions (metal-
ligand),44,45 halogen bonding,46,47 π···π stacking,48-51 cation···π,52-54 anion···π,55-58 and C-
H···π,59,60 C-H···O and C-H···N interactions11,61-63 and van der Waals forces.64,65 However, In 
the preparation of organic supramolecular structures, hydrogen bond is a dominating and 
preferred non-covalent interaction due to its specific and directive property in the solid states 
as well as in solutions. 4,10,11,66,67   
As shown in Fig. 4, specific functional groups of different molecules form strong 
hydrogen bonds and generate recurring H-bonded motifs in structures, such patterns are 
termed as ‘supramolecular synthons’.40 Formation of these precise and inherent hydrogen-
bonded interactions between the complementary functional groups is a well known rational 
criteria to obtain the new organic supramolecular structures.40,68-72 
 
Figure 4: Synthon formation from complementary functional groups. 
Surveys of experimentally investigated crystal structures by Cambridge Structural 
Database (CSD)73,74 have showed that the ଶଶሺͺሻ motif [coded according to Etter’s 
nomenclature R = H-bonded ring, (8) = ring of 8 atoms, 2 = number of donors, and 2 = 
number of acceptors)75,76 is one of the most common H-bonded synthons. Such a H-bond 
pattern in the solid state can be obtained from molecules with a wide range of complementary 
functional groups such as carboxylic acid, amide77,78 amidine,79-82 urea,83-85 guanidinium-
carboxylate/phophonate/sulfonate/nitro or boronic acid etc. (Fig. 1.2.2, a-l).86-90  
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Figure 5: Classical ଶଶሺͺሻsupramolecular synthon formation from various functional groups in the 
solid state, a) a neutral homodimer from carboxylic acid and b) amide groups; c) A neutral 
heterodimer from carboxylic acid - amide d) amidines e) carboxylic acid - boronic acid, f) boronic acid 
- boronic acid, g) mixed neutral - anionic, boronic acid - carboxylate, h) urea - carboxylate,  e) 
zwitterionic from guanidinium - carboxylate, f) guanidinium - sulfonate g) guanidinium - phosphate 
and h) guanidinium - nitro groups. 
The ଶଶሺͺሻ motif and other various specific H-bonded patterns not only help to design 
the new supramolecular synthetic strategies, but also offer the ideas to prepare aesthetic and 
application-oriented new molecular assemblies, which are quite difficult to obtain by 
traditional-covalent synthesis.91,92 The resulting structures with varying properties are 
vindicated as useful materials in the field of optical activity, conductivity (salt bridges), 
magnetism, sensors, material science, theoretical science and as artificial receptors in bio-
chemical molecular recognitions etc.41,93-95 
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Chapter 1  
Microporous Dipeptide Structures 
1.1 Introduction: Amino acids, Peptides and Proteins  
In nature there are 20 common amino acids, every single one of them functioning as a basic 
building block for proteins. Except glycine, all amino acids possess a stereogenic Cα-atom 
with absolute L-configuration that covalently holds an amino group, a carboxylic acid group 
and a side chain that has different chemical and physical property such as hydrophobic, polar, 
acidic, basic or neutral (Fig. 1.1.1). 
 
Figure 1.1.1: The structure and chemical properties based classification of 20 natural amino acids 
shown with three-letter abbreviations and one-letter symbols. 
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Peptides are chains of amino acids linked together by peptide bonds, and when many amino 
acids join in a single linear chain it is called a polypeptide. In a peptide chain each amino acid 
part is referred as a residue (Fig. 1.1.2). One or more polypeptide chains can fold through 
non-covalent interactions into secondary structures, which hierarchically builds a functional 
compact domain in a native protein or enzyme.1-3 (Fig. 1.1.3, Chapter 1). Proteins are 
abundantly occurring biopolymers in all cells of living beings and serve a central role in 
various biological and physiological processes. Distinct proteins with various lengths and 
diverse structural forms participate in different functions4 such as enzymatic catalysis 
(enzyme that speeds the chemical reaction),5,6 in transportation of essential ions or molecules 
across the cell membrane,7,8 in muscular movements as contractile proteins (actin and 
myosin),9 and acts as hormones,10 neurotransmitters11,12 and as antibodies in immune 
systems,13 etc.  
 
Figure 1.1.2: A schematic representation of amino acid to protein structure build up. 
1.1.2 Small Peptides (Natural vs Synthetic Peptides) 
Contrary to the biological proteins, small peptides with desired sequence and length can be 
easily prepared in the laboratory. Such peptide fragments can be used as potential drug 
candidates.14-16 Moreover, their natural tendency of self-assembly adds an advantage in 
‘bottom-up’ approach17 (larger assemblies from smaller units, while ‘top-down’ is to carve 
smaller from larger) to build the efficient and useful nano-scale biomaterials.18-27 Such 
structures can function as excellent materials for asymmetric catalysts,28 as gelators,29,30 nano-
vesicles for various bio-medicines,31 drug delivery vehicles,32 in regenerative medicines,33,34 
and more importantly as bio-mimetic devices in clinical-biology.25,35-40  
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1.1.3 Nanoporous Self-assembly of Dipeptides and Material Science 
A dipeptide is the smallest representative molecule of a protein; generally existing in a 
zwitterionic form, containing a characteristic peptide bond and behaving as a model for 
precise structure geometries and hydrogen-bonded self-organization of proteins. 
 
Nearly for two decades our research group is engaged in an interdisciplinary field of 
structural and materials property investigations of small peptides, particularly in zwitterionic 
dipeptide structures.41-70 There have been tremendous outcomes throughout this period, 
especially from the molecules that are composed of hydrophobic amino acids such as Ala, 
Val, Leu, Ile, Phe, Met and Trp43 (all amino acids and dipeptides mentioned in this 
dissertation are of the L-configuration, thus stereochemical indicators are not included). 
Almost 50% of the investigated dipeptides show porous structures formation,43 the rest 
generate non-porous networks in the solid states. According to the three-dimensional 
structures and H-bonding properties,43 the porous dipeptides are divided into the Val-Ala class 
and the Phe-Phe class. A rare additional example of porous dipeptide includes Ser, a polar 
residue, in Leu-Ser.44 The Val-Ala and Leu-Ser classes produce the hydrophobic micropores, 
while the Phe-Phe class generates hydrophilic channels in highly stable H-bonded networks 
(Fig. 1.1.3).43 In the modern nano-science discipline, the porous molecular structures or 
assemblies are in the demand as futuristic smart materials for growing field of 
applications.71,72 Therefore, we focus here mainly upon studies related to the porous dipeptide 
structures. 
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Figure 1.1.3: Representative molecular structures, crystal packing arrangement and channel shapes of 
nanoporous dipeptide classes, a) Val-Ala [Cambridge Structure Database (CSD v5.34 Nov.2012)73, 
refcode WIRYEB41], b) Leu-Ser (JAZBOC)44 and d) Phe-Phe (IFABEW).45  
1.1.3.1 Self-assembly of the Val-Ala Class Dipeptides 
 
The first ever dipeptide structure reported by our group is Val-Ala,41 which is an interesting 
chiral small molecule and formed a stable self-assembly with nano-porous structural property. 
Subsequent investigations of dipeptides predominantly combining Ala, Val and Ile residues 
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have added numerous members in this series named the Val-Ala class.49 To date, this is the 
major group of porous dipeptides including seven molecules with similar hydrogen-bonding 
patterns (Fig. 1.1.3.1.a),41,49 but different pore dimensions and surface areas due to variable 
aliphatic side chain lengths and size (Fig. 1.1.3.1.b). Ala-Ala is composed of smallest Ala 
residue, inspite the similar peptide backbone as Val-Ala it generates a nonporous structure 
with different crystal packing.74 Obviously, the steric crowding of bulky sec-butyl side chains 
of Ile-Ile forces structure to form a densely packed 3D arrangement.63 However, when Ala is 
coupled with Val or Ile it creates the porous structures (Fig. 1.1.3.1.b). 
a) b)  
Figure 1.1.3.1: a) A representative hydrogen-bonded peptide backbone of the porous Val-Ala class of 
dipeptides is shown. The region occupied by hydrophobic amino acid side chains is shown with light-
blue shade. b) Dipeptides belonging to a Val-Ala class are listed according to their pore diameters, 
channel surface areas and CSD refcodes. Ala-Ala and Ile-Ile form non-porous structures.63,74 The 
channel diameters and surface areas were calculated by the program Mercury.75  
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1.1.3.2 Self-assembly of Leu-Ser Dipeptide 
          
Figure: 1.1.3.2:  Molecular structure of Leu-Ser (JAZBOC).44 A single channel in Leu-Ser assembly 
is shown (5.0 Å diameter, unit cell volume = 9.3 %, void volume = 163.5 Å3).76 For clarity, Leu side 
chains aligned around the channel (light blue shade) are drawn as thin black wires and the H-bonded 
peptide backbone in capped sticks.  
Leu-Ser also generates porous structure, but due to involvement of hydroxyl group of Ser 
residue (Fig. 1.1.3.2a) it acquires a different H-bonding network (Fig. 1.1.3.2b)44 than that of 
the Val-Ala class of molecules (Fig. 1.1.3.1a). In the past, there have been efforts to prepare 
the additional Leu-Ser type of structures with wider channels by replacing Leu with Val, a 
residue with one C-atom less than the Leu side chain. The resulting Val-Ser in fact has been 
found to form a non-porous dihydrate (FOBLUE)58 and a porous Val-Ala class-related 
monoclinic solvate with Z’ = 3 (CAZGOA)51. Among the same category of dipeptides, Ala-
Ser (LALLSE)77 showed a compact 3D H-bonded structure, while the highly hydrophobic N-
terminal residue generated layered structures [Phe-Ser (MAZYAO), Ile-Ser (MAZXUH) and 
Met-Ser (MAZYES)].56 Thus, the Leu-Ser class of dipeptide has so far exhibited only single 
porous member, i.e. Leu-Ser itself (Fig. 1.1.3.2).44  
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1.1.3.3 Self-assembly of the Phe-Phe Class Dipeptides 
The Phe-Phe class, in addition to Phe-Phe (IFABEW) includes Leu-Leu (IDUZOW), Ile-Leu 
(ETITUW), Leu-Phe (EDUZUC) and Phe-Leu (IFABAS)45 dipeptides and also the additional 
members, Phe-Trp (GEHTAP)70 and Trp-Gly (FULGEY).78 The unique characteristic feature 
of this class is the generation of hydrophilic channels by engaging four to six dipeptide 
molecules in a H-bonded helical chain in the periphery of channel axis (Fig. 1.1.3.3).43,45  
 
Figure: 1.1.3.3:  The representative Phe-Phe class members are shown. a) Phe-Phe (IFABEW)45 
molecular structure showing an organized chain of six Phe-Phe molecules around the open pore 
(diameter = ~10 Å, unit cell, void volume = 402 Å3). For clarity, the disordered water molecules inside 
the channel have been omitted. b) Leu-Leu (IDUZOW)45 and c) Trp-Gly (FULGEY)78 are showing the 
crystal packings involving four dipeptide molecules around the pore of respective structure. Water 
filled channels are shown with the light-blue shades. In a-c) the atoms of polar peptide backbones 
involved in hydrogen bondings are drawn as ball and stick. 
1.1.3.4 Side Chain Size, Orientations and Channel Property 
From the experimentally well-investigated dipeptide structures one can see the importance of 
the main chain conformation of dipeptides which is an important factor for their self-assembly 
and the nature of the pores formed, hydrophobic or hydrophilic. When the side chains acquire 
positions on opposite sides of the peptide plane (θ and φ both close to 180°) the structure 
forms a hydrophobic pore (in Val-Ala and Leu-Ser classes).49,44 Alternatively, when the side 
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chains of dipeptide are located on same side of the peptide plane (θ and φ both close to 0°) it 
forms hydrophilic channel in the structures (FF class)45 (Fig. 1.1.3 and Fig. 1.1.3.4). 
 
Scheme 1.1.3 The schematic representions showing the torsion angle symbols used for a dipeptide. 
    
Figure: 1.1.3.4:  Representative dipeptides with bulkier side chains showing difference in side chain 
orientations (θ and φ torsions) in a) Val-Ile, b) Ile-Val, molecules of the Val-Ala class, and c) Phe-Phe 
d) Leu-Leu members of the FF class. a) and b) are hydrophobic pore formers, whereas,  c) and d) are 
hydrophilic channel formers. 
1.1.4 Rational Strategies for Channel Size Modifications 
In recent years, the microporous Val-Ala and Leu-Ser classes of small-molecular assemblies 
have been successfully examined as materials for CO2, methane and hydrogen gas absorption 
and separation, and also as a catalyst.79-82 Whereas, the Phe-Phe structure (Fig. 1.1.1.3a), due 
to its stability83 and wide pore dimensions, is an extensively exploited molecule as an 
advanced material in the diverse nano-technological applications.84,21,35,85 Also, Phe-Phe 
constitutes the recognition motif in Alzheimer’s β-amyloid fibrils, thus the self-assembly of 
FF is also well studied for clinical reasons.21,45,86,87 
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Molecular structures with nanoporous properties are great in demand for emerging 
nano-scale applications.25,33,35,36,38,72,87-91 Hence, herein we continue our research efforts in 
this area to investigate the novel structural, specifically, microporous properties of bio-derived 
small molecules. For this, we decided to design a strategy based on previously studied porous 
dipeptides and take the advantage from the residues with bulky aliphatic side chains, which 
organize in the periphery of the channel, mainly in the Val-Ala and Leu-Ser class of 
structures, as shown in Fig. 1.1.4.1. From this approach we envisaged that increased pore 
dimensions in such structures could potentially be achieved by replacing bulkier side chains 
of Val and Ile in VA class, or Leu of LS, with side chains of Abu or Nva (ethyl or n-propyl 
groups) (Fig. 1.1.4.2). 
In addition, although Pro is a cyclic side chain containing amino acid, it possesses 
three methylene C atoms, still a C atom less than Leu side chain, therefore we planned to 
include Pro along with Ser in a dipeptide to verify the compatibility and effect of structural 
diversity in the porous structure formation.  
 
Figure 1.1.4.1 a) Crystal packing of Val-Ile view along the hexagonal axis. Val-Ile is a Val-Ala class 
member and generates the narrowest pore.43 b) Crystal packing of Leu-Ser. The hydrogen bonded 
peptide backbones in a) and b) are drawn as capped sticks. 
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Figure 1.1.4.2: The structures of aliphatic side chain containing proteinogenic and non-proteinogenic 
amino acids. 
Some dipeptide structures due to bulky hydrophobic side chains of both the residues 
do not leave a space as a pore and instead generate closely-packed structures. e.g. Leu-Ile 
(ETIWIN)50 or (HIZCOJ)62 and Ile-Ile (YAGZOW).63 Looking at these molecules we 
predicted a pore formation if a Leu or Ile or both are replaced by the less bulky ethyl (Abu) or 
n-propyl (Nva) side chain. Another an interesting fact is that Ala-Ile and Ile-Ala form porous 
structures, but their structurally isomeric counterparts Ala-Leu (DEZQOO)67 and Leu-Ala 
(RAVMOQ)68,92 are nonporous. Hence we thought it would be interesting to check the effect 
of the combination of the intermediately sized side chain of Abu (ethyl) or Nva (n-propyl) 
along with the Ile or Leu. 
Previously, in the search for larger pores than in the Ala-Val and Val-Ala crystals, the 
commercially available Ala-Abu and Abu-Ala molecules have been analyzed,47,48 but their 
structures resulted into non-porous molecular networks. 
Conversely, the molecules of the Phe-Phe class of dipeptides form hydrophilic pores 
by pointing hydrophobic side chains away from the channel (Fig. 1.1.3.3), which further 
limits the pore size fine tuning based on side chain modifications. Also such fabrication in the 
Phe-Phe (IFABEW), Phe-Trp (GEHTAP) and Trp-Gly (FUGLEY) molecules is almost 
impossible because of their rigid aromatic side chain properties (Fig. 1.1.3.3a and Fig. 
1.1.3.4c). However, the other members in the Phe-Phe class such as Leu-Leu (IDUZOW),45 
Ile-Leu (ETITUW),50 Leu-Phe (IDUZUC)45 and Ile-Phe (ETONIK)61 (Fig. 1.1.4.3) contain 
residues with aliphatic side chains, thus to some extent we saw room to replace Leu and Ile by 
Abu or Nva. Therefore, we presumed that these replacements may favor a change in the 
structures in such a way that the forming network would either; adapt the six molecules in a 
H-bonded chain to generate a larger pores [(as seen in Phe-Phe (IFABEW)] or the structures 
with change in their θ and φ torsions, and thus can give rise to hydrophobic channels or the 
structures with other properties.   
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According to these strategies for substitutions of bulky amino acids with Abu or Nva 
one can obtain wider channels with additional surface areas. Incorporation of such fine 
structural modifications in the Val-Ala, Leu-Ser and Phe-Phe classes presumably may offer 
numerous assemblies with fine-tuned nanotube diameters for variety of uses, here especially 
for the CO2 and methane gas absorption and selectivity studies.  
 
Figure 1.1.4.3: The crystal packing of a) Ile-Leu (ETITUW),50 b) Leu-Phe (IDUZUC)45 and c) Ile-Phe 
(ETONIK)61 molecules. The Leu and Ile side chains have been shown with the black thin wires. Light 
blue shades in a) and b) represent the water-filled channels, whereas in c) it shows a two-dimensional 
hydrophilic layer. The hydrogen bonds are shown with the dotted lines.  
Here, it is necessary to mention that both Abu and Nva are non-proteinogenic amino 
acids, but according to their successful use in biological studies they can be considered as bio-
compatible molecules. A physiological testing showed that Nva has arginase inhibitory 
property, which regulates the nitric oxide (NO) production in mammals,93 and also acts as an 
anti-inflammatory agent,94  whereas Abu is an active precursor used in anticonvulsant drug 
molecules such as Brivaracetam,95 Levetiracetam96 as well as in the antituberculotic agent 
Ethambutol.97     
1.1.5 Synthetic Targets as Microporous Dipeptides (Summary of Designed  
Molecules) 
As explained above, this study is a thorough structure-based strategy to obtain 
different dimensions of nanotubes in dipeptide assemblies. Since the dipeptides composed of 
Abu or Nva and other standard amino acids are not commercially available, we planned in-
house synthesis of such target molecules to demonstrate experimentally the presumptions of 
various types of pore formation in hydrophobic dipeptides. 
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1.1.5.1 Val-Ala Class 
  Table 1.1.5.1: Synthetic targets in the Val-Ala class. 
  C-terminal residue  
  Ala Abu Nva Val Ile 
N-terminal 
residue 
Abu ---- Abu-Abu Abu-Nva Abu-Val Abu-Ile 
Nva Nva-Ala Nva-Abu Nva-Nva Nva-Val Nva-Ile 
              
 
1.1.5.2 Leu-Ser Class 
 
    
                                                 
          
 
 
 
1.1.5.3 Phe-Phe Class 
      
 
 
Table 1.1.5.2: Synthetic targets in the Leu-Ser. 
class 
  C-terminal residue 
  Ser 
N-terminal 
residue 
Abu Abu-Ser 
Nva Nva-Ser 
Pro Pro-Ser 
Table 1.1.5.3: Synthetic targets in the Leu-Ser class. 
  C-terminal residue 
  Leu Phe 
N-terminal 
residue 
Abu Abu-Leu Abu-Phe 
Nva Nva-Leu Nva-Phe 
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1.1.6 Synthesis, Crystallization and Structure Determination of Dipeptides 
There are numerous solid-phase as well as traditional liquid-phase synthetic methods 
available for the preparation of peptides.98,99 For ligation of amino acids here we have used a 
convenient and efficient solution-phase process by employing N, N’-dicyclohexyl- 
carbodiimide (DCC) and N-hydroxysuccinimide (NHS) (Scheme 1.1.6). These reagents were 
readily available in the laboratory as left-over chemicals from previous users. Since 
dicyclohexyl urea (DCU), a by-product formed from DCC after active ester formation of the 
N-terminal residue with NHS, is insoluble in dichloromethane (CH2Cl2), it can be filtered off 
easily. After the peptide coupling reaction, the regenerated and water soluble NHS is also can 
be readily removed by water washings.100-102 Thus, we chose to include these reagents in 
synthetic processes to avoid subsequent laborious purification complications of chemically 
sensitive peptide molecules. In accordance with the process requirements, the Boc- or Cbz- 
protected amino acids were used at N-terminals. All the non-protected amino acids, O-benzyl 
serine, 10% Pd/C and 4M HCl in dioxane were purchased from Sigma-Aldrich and used as 
received. For the synthetic and crystallization experimental details see section 1.4  
 
Scheme 1.1.6: General synthetic scheme for the dipeptides in this work.  
Reagents and conditions: a) i) (Boc)2O OR Cbz-Cl b) i) DCC, NHS, CH2Cl2, ii) AA, NaHCO3,                          
H2O, Acetone, RT;  c) i) HCl, RT OR H2, Pd/C, ii) Aq. NaOH, pH = 7-8. 
1.1.6.1 Synthesis of Val-Ala and Phe-Phe Class of Dipeptides 
For the synthesis of Val-Ala and Phe-Phe group of molecules (Table 1.1.5.1 and Table 1.1.5.3) 
where the side chains of amino acids are devoid of any chemically reactive groups, we used 
common methods. 
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1.1.6.2 Synthesis of Leu-Ser Class of Dipeptides 
The C-terminal residue Ser contains a polar hydroxyl group, thus a benzyl protected serine 
was used. Also, depending upon the feasibility of the process, the Boc- or Cbz- protected N-
terminal residue was employed.   
1.1.6.3 Crystal Preparation and Structure Determination   
After the synthesis of targeted dipeptide molecules, their crystallization was the main bottle-
neck in accomplishing this study. Subsequently by trial-and-error of slow evaporation of 
water/organic solvents (methanol, ethanol, 2-propanol (IPA) etc.) and various solvent 
diffusion methods for the crystallizations were attempted. We noticed that gel crystallization 
was the most effective method for small quantities, but large quantities of Nva-Nva, Nva-Val, 
Nva-Ile and Abu-Ile crystals for CO2 and methane gas absorption studies were obtained by 
slow evaporation of water.  
Single crystal X-ray diffraction experiments for all crystalline dipeptides were carried 
out on a Bruker APEXII103 CCD detector diffractometer with graphite-monochromatized (Mo 
Kα = 0.71073 Å) radiation at 105 K by continuous flow of liquid nitrogen controlled by an 
Oxford low-temperature device. Data were collected with an ω scan width of 0.5° at different 
settings of φ (0°, 90° and 180°) with the detector fixed at 2θ = ‒30°. Data 
integration/reduction and absorption was carried out by SAINT and SADABS,103 respectively 
and refinement by SHELXTL.104 All refinement details are described in the respective 
manuscripts. Molecular and packing illustrations for the thesis and manuscripts were 
generated by using the program Mercury.75  
1.2 Results and Discussions : Crystal Structures of Obtained Dipeptides 
Val-Ala class: In this category, out of nine synthesized molecules (Table 1.1.5.1), all except 
Nva-Ala formed crystals of X-ray diffractions quality. All the analyzed structures show a 
common hexagonal P61 space group and belong to the porous VA family with different 
channels sizes and shapes in identical H-bonded networks.  
Abu-Ser, Nva-Ser and Pro-Ser (Table 1.1.5.2) were synthesized in substantial quantities. 
While Abu-Ser and Pro-Ser formed single crystals, Nva-Ser, which was regarded as the most 
likely additional member of the Leu-Ser class, remained as a powder even after several 
crystallization attempts by various methods (slow evaporation, solvent diffusion and gel etc). 
23 
 
Abu-Leu, Nva-Leu and Nva-Phe (Table 1.1.5.2) were obtained as crystalline specimens 
necessary for X-ray diffraction study, but Abu-Phe did not form crystals. Surprisingly, the 
structures from X-ray diffraction data revealed that both Abu-Leu and Nva-Leu belong to the 
Val-Ala class of molecules with equivalent crystallographic properties (hexagonal unit cell, 
P61 = space group) (Table 1.2).  
Table 1.2: Summary of crystallized dipeptides and their structural properties. 
Class Val-Ala Leu-Ser Phe-Phe 
Molecules 
Abu- 
Abu 
Abu-
Nva 
Abu-
Val 
Abu-
Ile 
Nva-
Abu 
Nva-
Nva 
Nva-
Val 
Nva-
Ile 
Abu-
Ser 
Abu-
Pro 
Abu-
Leu 
Nva-
Leu 
Nva-
Phe 
Space 
group 
P61 I4 P21 P61 P212121 
Unit cell Hexagonal 
Tetra- 
gonal 
Mono- 
clinic 
Hexagonal 
Orthor- 
hombic 
Porous/non-
porous 
Porous Non-porous Porous 
Non-
porous 
 
1.2.1 Val-Ala Type Structures 
According to crystal data and three-dimensional structure properties (Table 1.2), we have 
obtained a total of ten new members of the Val-Ala class. For a convenient description of 
these molecules in further discussions we renamed them as 1-10, (Scheme 1.2.2).  
 
Scheme 1.2.2: The Val-Ala class of dipeptides 1-10 in present work 
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Figure 1.2.2: The atomic labeling schemes of dipeptides 1-10 showing molecular conformations. 
Thermal ellipsoids are drawn at the 50% probability level. In the Nva series (6-10), the N-terminal side 
chain is disordered, and the alternate sites are shown as thin wires.    
To avoid the repetition, the elaborate details of molecular structures, self-assembly, H-
bonding of 1-10, and CO2 and methane absorption study results are presented in the 
Publication I. 
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1.2.2 Structures of Abu-Ser and Pro-Ser 
 
Both Abu-Ser and Pro-Ser form non-porous structures. Abu-Ser yielded an unusual tetragonal 
I4 space group, like the structure of Ala-Ala,74 whereas Pro-Ser crystallizes into a chiral 
monoclinic P21 space group, which includes an ordered chain of water molecules in the 
crystal lattice. Details of Abu-Ser and Pro-Ser structures are explained in Publication II and 
III, respectively. 
1.2.3 Structure of Nva-Phe 
 
Nva-Phe forms a dihydrate in orthorhombic crystals and generates a layered H-bonded 
network. A complete structural description can be found in Publication IV.  
1.3 Conclusions 
This study constitutes a comprehensive structure based rational design and combinatorial 
synthetic strategy for detailed investigations of nanoporous materials as well as structural 
properties of bio-degradable small molecules. Out of a total of 15 synthesized novel 
dipeptides, 13 were successfully obtained as crystals. All molecules in the Val-Ala class of 
dipeptides formed nanotubes. This is by far the largest family of nanoporous organic materials 
known, including 17 different molecules (seven earlier and ten molecules from present study). 
Such an extensive topology-based approach led to the understanding and confirmation of the 
optimum micropore formation ability of the dipeptide molecules, especially in the Val-Ala 
and Leu-Ser classes. The formation of hydrophobic channels in Abu-Leu and Nva-Leu 
suggest that a small structural change can divert self-assembly into an unexpected very stable 
open channel formation. Even though Pro-Ser did not form any kind of pores, structurally it 
was a worthwhile self-assembly due to its inclusion of water wires. This is a one of the bio-
26 
 
mimicking molecular property showed by Pro-Ser because Pro residue is a member of the 
significant NPA (Asn-Pro-Ala) motif of aquaporin, a biological water channel.7 Besides Ile-
Phe (ETONIK), and Val-Phe (MOBYAD)69 (Fig. 1.1.4.3 c), the Nva-Phe is an additional new 
member we found with rare structural property of layer formation. The pore dimensions 
enhancement upon side chain bulk reduction is not only observed in narrow pore forming 
members of Val-Ala class, but also this approach generated the porous (Nva-Nva, Abu-Nva, 
Nva-Abu, Abu-Leu, Nva-Leu, Abu-Ile and Nva-Ile) structures from completely non-porous 
structures (Ile-Ile or Leu-Leu). 
Keywords: hydrophobic dipeptides, nanotubes, bio-degradable material, self-assembly, non-
proteinogenic amino acids, hydrophobic channels. 
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1.4 Experimental and Characterization Data 
Dipeptides synthesis: By incorporating two non-proteinogenic (Abu and Nva) and various 
proteinogenic amino acids we have opted for the following synthetic methods (scheme 1 and 2) to 
prepare the 16 novel dipeptides with substantial yields. The structures of synthesized intermediates 
and final compounds were confirmed by mass spectrometry (MS), NMR (1H-NMR and 13C-NMR) and 
optical rotation (wherever it was necessary). The three-dimensional structures of 13 zwitterionic-
crystalline dipeptides have been analyzed by X-ray diffraction methods. 
a) Synthesis of Dipeptides from Hydrophobic Amino acids 
 
Scheme 1: Synthesis of dipeptides 1-10, Nva-Ala, Abu-Phe and Nva-Phe.  
Reagents and conditions: a) i) (Boc)2O, THF, NaOH; b) i) DCC, N-Hydroxysuccinimide, CH2Cl2,  
ii) AA, NaHCO3, H2O, Acetone, RT; c) i) HCl, RT, ii) Aq. NaOH, pH = 7-8. 
 
Synthesis of (S)-2-(tert-butoxycarbonylamino)butanoic acid (Boc-Abu) 
L-2-aminobutyric acid (3.0 g, 29.0 mmol) was added to the chilled (5-0 °C) solution of a 1:1 
tetrahydrofuran (THF): water mixture (50 mL). To this solution 5 mL aq. NaOH (1.03 g, 2.56 mmol) 
was added over 10 minutes. At the same temperature, di-tert-butyl dicarbonate ((Boc)2O, 7.7 mL, 35.0 
mmol) was added and turbid mixture stirred at room temperature (RT) for 24 h, until it became clear. 
After the reaction was complete, the THF was removed at 30 °C under reduced pressure and 
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remaining aq. residue was washed with diethyl ether (20 ml x 2), and the ether extract discarded. The 
aq. residue was cooled to 5-0 °C and acidified with saturated KHSO4 solution (pH 2-3). The acidic aq. 
mixture was extracted with fresh diethyl ether (30 mL x 3) and the combined ether layers were washed 
with water and brine solutions (20 mL each) separately and dried over anhydrous MgSO4 and filtered 
through Whatmann filter paper. The evaporation of diethylether under vacuum afforded Boc-Abu. 
Yield = 5.5 g (93%).   
Optical rotation: [α] ଶ଴ହ଼ଽ= ‒16.8 (c = 1 g/100 mL, MeOH).  
1H-NMR (300MHz, DMSO-d6), δ = 12.45 (bs, 1H), 7.02-6.99 (d, 1H, J = 7.4 Hz), 3.83-3.75 (m, 1H), 
1.74-1.51 (m, 2H), 1.38 (s, 9H), 0.90-0.85 (t, 3H, J = 7.4 Hz). 
13C-NMR (75MHz, DMSO-d6), δ = 174.07 (COOH), 155.63 (CO), 77.95 (>C<), 54.91 (CH), 28.24 
(3CH3), 24.17 (CH2), 10.60 (CH3). 
    
(S)-2-(tert-butoxycarbonylamino)pentanoic acid ( Boc-Nva) 
Synthesis of Boc-Nva from L-norvaline (3.0 g, 25.6 mmol) and (Boc)2O (7.0 mL, 30.8 mmol) was 
achieved according to the procedure reported for Boc-Abu. Yield = 5.3 g (95%). 
Optical rotation: [α] ଶ଴ହ଼ଽ= ‒13.6 (c = 1 g/100 mL, MeOH). 
1H-NMR (300MHz, DMSO-d6), δ = 12.39 (s, 1H), 7.02-7.00 (d, J = 8.1 Hz, 1H), 3.90-3.82 (m, 1H), 
1.62-1.50 (m, 2H), 1.38-1.30 (m, 11H), 0.88-0.83(t, J = 7.3 Hz, 3H).   
13C-NMR (75MHz, DMSO-d6), δ = 174.31 (COOH), 155.60 (CO), 77.91 (>C<), 53.14 (CH), 32.88 
(CH2), 27.99 (3CH3), 18.82 (CH2), 13.48 (CH3). 
  
(S)-2-((S)-2-(tert-butoxycarbonylamino)butanamido)butanoic acid (Boc-1, Boc-Abu-Abu) 
In a 50 mL dry round bottom flask (RBF) under nitrogen atmosphere, 10 mL of dry CH2Cl2 
(dichloromethane) was charged and cooled to 10 °, then Boc-Abu (0.60 g, 2.95 mmol), 
dicyclohexylcarbodiimide (DCC) (0.67 g, 3.25 mmol) and N-hydroxysuccinimide (NHS, 0.40 g, 3.45 
mmol) were added. The reaction mixture was warmed to RT and stirred for 2 h. From reaction 
suspension, the undissolved byproduct dicyclohexyl urea (DCU) was removed by filtration through a 
celite bed. The CH2Cl2 was removed from the filtrate under reduced pressure to obtain the 
intermediate Boc-Abu succinate ester (1g), which was then redissolved in acetone (10 mL). In separate 
flask, L-2-aminobutyric acid (Abu, 0.30 g, 2.95 mmol), NaHCO3 (0.84 g, 10.0 mmol) and 10 mL of 
water were charged at RT. To this, the premixed Boc-Abu succinate ester in acetone was added over 
15 min and stirred vigorously for 30 min. Acetone from the reaction was evaporated under reduced 
pressure and residual water was extracted with 20 mL of diethyl ether. The remaining water layer was 
diluted with the additional 10 mL of water and cooled to 0 °C, and slowly acidified with aq. 1M HCl 
solution (pH = 2-3). The acidic aq. solution was extracted with diethyl ether (30 mL x 3) and 
combined extract was washed with brine and water (10 mL each). The ether extract was dried over 
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anhydrous MgSO4, filtered, and solvent removed under reduced pressure yielding Boc-Abu-Abu (Boc-
1). Yield = 0.69 g (72%). 
MS CI+ m/z (relative intensity in %) = [M+H]+ 289 (50), 233 (85), 189 (100), 58 (58)   
1H-NMR (300MHz, CDCl3-d), δ = 9.00 (bs, 1H), 6.90-6.87 (d, J = 7.4 Hz, 1H), 5.31-5.28 (m, 1H), 
4.59-4.53 (m, 1H), 4.12-3.09 (d, J = 8.5 Hz, 1H),  2.03-1.57 (m, 4H), 1.43 (s, 9H), 0.97-0.91 (m, 6H).  
13C-NMR (75MHz, CDCl3-d), δ = 175.09 (COOH), 172.50 (CON), 156.12 (CO), 74.83 (>C<), 55.97 
(CH), 53.46 (CH), 28.42 (3CH3), 25.76 (CH2), 25.38 (CH2), 10.08 (CH3), 9.57 (CH3).  
 
(S)-2-((S)-2-(tert-butoxycarbonylamino)butanamido)pentanoic acid (Boc-2, Boc-Abu-Nva) 
Boc-2 was synthesized from Boc-Abu (0.60 g, 2.95 mmol) and L-norvaline (0.35 g, 3.0 mmol) 
according to the procedure reported for Boc-1. Yield = 0.77 g (77%). 
MS CI+ m/z (relative intensity in %) = [M+H]+ 303 (35), 247 (85), 203 (100), 58 (50).  
1H-NMR (300MHz, CDCl3-d) δ = 9.18 (s, 1H), 6.92-6.89 (d, J = 7.8 Hz, 1H), 5.37-5.34 (m, 1H), 4.65-
4.58 (m, 1H), 4.13-4.10 (d, J = 8.1 Hz, 1H), 1.95-1.61 (m, 4H), 1.46-1.33 (m, 11H), 1.01-0.91 (m, 
6H).   
13C-NMR (75MHz, CDCl3-d) δ = 175.52 (COOH), 172.55 (CON), 156.14 (CO), 80.51 (>C<), 55.81 
(CH), 52.20 (CH), 34.29 (CH2), 28.40 (3CH3), 25.67 (CH2), 18.64 (CH2), 13.77 (CH3), 10.07 (CH3). 
 
(S)-2-((S)-2-(tert-butoxycarbonylamino)butanamido)-3-methylbutanoic acid (Boc-3, Boc-Abu-
Val)  
Boc-3 was synthesized from Boc-Abu (0.60 g, 2.95 mmol) and L-valine (0.35 g, 3.0 mmol) according 
to the procedure reported for Boc-1. Yield = 0.81 g (81%). 
MS CI+ m/z  (relative intensity in %) = [M+H]+ 303 (57), 247 (100), 203 (100), 58 (50). 
1H-NMR (300MHz, CDCl3-d) δ = 6.88-6.86 (d, J = 8.7 Hz, 1H), 6.48 (bs, 1H), 5.30-5.28 (d, J = 5.0 
Hz, 1H), 4.61-5.56 (m, 1H), 4.13-4.10 (d, J = 8.2 Hz, 1H), 2.30-2.21 (m, 1H), 1.91-1.81 (m, 1H), 1.71-
1.61 (m, 1H), 1.45 (s, 9H), 1.02-0.94 (m, 9H).  
13C-NMR (75MHz, CDCl3-d) δ = 174.90 (COOH), 172.66 (CON), 156.19 (CO), 80.49 (>C<), 57.19 
(CH), 56.04 (CH), 31.19 (CH), 28.43 (3CH3), 25.54 (CH2), 19.11 (CH3), 17.70 (CH3), 10.13 (CH3). 
 
(S)-2-((S)-2-(tert-butoxycarbonylamino)butanamido)-4-methylpentanoic acid (Boc-4, Boc-Abu-
Leu) 
Boc-4 was synthesized from Boc-Abu (0.60 g, 2.95 mmol) and L-leucine (0.39 g, 3.00 mmol) 
according to the procedure reported for Boc-1. Yield = 0.84 g (79%). 
MS CI+ m/z (relative intensity in %) =  [M+H]+ 317 (55), 261 (96), 217 (100), 58 (50). 
1H-NMR (300MHz, CDCl3-d) δ = 9.86 (bs, 1H), 6.81-6.79 (d, J = 8.7 Hz, 1H), 5.34-5.31 (d, J = 8.2 
Hz, 1H), 4.64- 4.57 (m, 1H), 4.08-4.06 (d, J = 8.5 Hz, 1H), 1.90-1.53 (m, 5H), 1.43 (s, 9H), 0.96-0.92 
(m, 9H). 
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13C-NMR (75MHz, CDCl3-d) δ = 176.10 (COOH), 172.65 (CON), 156.15 (CO), 80.51 (>C<), 55.89 
(CH), 50.90 (CH), 41.29 (CH2), 28.40 (3CH3), 24.91 (CH2), 23.03 (CH), 21.89 (CH3), 10.07 (CH3). 
(2S, 3S)-2-((S)-2-(tert-butoxycarbonylamino)butanamido)-3-methylpentanoic acid (Boc-5, Boc-
Abu-Ileu) 
Boc-5 was synthesized from Boc-Abu (0.58 g, 2.85 mmol) and L-isoleucine (0.38 g, 2.90 mmol) 
according to the procedure reported for Boc-1. Yield = 0.74 g (81%). 
MS CI+ m/z (relative intensity in %) = [M+H]+ 317 (52), 261 (90), 217 (99), 58 (48). 
1H-NMR (300MHz, CDCl3-d) δ = 9.37 (bs, 1H), 6.89-6.86 (d, J = 8.6 Hz, 1H), 5.32-5.29 (d, J = 8.6 
Hz, 1H), 4.62-4.58 (m, 1H), 4.11-4.06 (m, 1H), 2.03-1.89 (m, 1H), 1.87-1.75 (m, 1H), 1.72-1.56 (m, 
1H), 1.53-1.43 (m, 10H), 1.28-1.13 (m, 1H), 0.96-0.89 (m, 9H). 
13C-NMR (75MHz, CDCl3-d) δ = 175.04 (COOH), 172.52 (CON), 156.16 (CO), 80.49 (>C<), 56.62 
(CH), 55.93 (CH), 37.79 (CH), 28.41 (3CH3), 25.52 (CH2), 25.05 (CH2), 15.52 (CH3), 11.71 (CH3), 
10.11 (CH3). 
 
(S)-2-((S)-2-(tert-butoxycarbonylamino)pentanamido)butanoic acid (Boc-6, Boc-Nva-Abu) 
Boc-6 was synthesized from Boc-Nva (0.50 g, 2.30 mmol) and L-2-aminobutyric acid (0.24 g, 2.33 
mmol) according to the procedure reported for Boc-1. Yield = 0.60 g (84%). 
MS CI+ m/z (relative intensity in %) = [M+H]+ 303 (57), 247 (80), 203 (100), 72 (48). 
1H-NMR (300MHz, DMSO-d6), δ = 12.62 (bs, 1H), 7.88-7.86 (d, J = 7.6 Hz, 1H), 6.83-6.80 (d, J = 
7.6 Hz, 1H), 4.16-4.09 (m, 1H), 3.98-3.90 (m, 1H), 1.78-1.20 (m, 15 H) 0.89-0.82 (m, 6H).  
13C-NMR (75MHz, DMSO-d6) δ = 173.36 (COOH), 172.25 (CON), 155.26 (CO), 77.98 (>C<), 53.91 
(CH), 52.98 (CH), 34.12 (CH2), 28.19 (3CH3), 24.43 (CH2), 18.62 (CH2), 13.69 (CH3), 10.08 (CH3).  
 
(S)-2-((S)-2-(tert-butoxycarbonylamino)pentanamido)pentanoic acid (Boc-7, Boc-Nva-Nva) 
Boc-7 was synthesized from Boc-Nva (0.52 g, 0.24 mmol) and L-norvaline (0.28 g, 0.25 mmol) 
according to the procedure reported for Boc-1. Yield = 0.59 g (77%). 
MS CI+ m/z (relative intensity in %) = [M+H]+ 317 (43), 261 (70), 217 (100), 72 (61). 
1H-NMR (300MHz, CDCl3-d) δ = 8.68 (bs, 1H), 6.88-6.85 (d, J = 8 Hz, 1H), 5.27-5.24 (d, J = 8 Hz, 
1H), 4.62-4.56 (m, 1H), 4.16-4.14 (d, J = 8.1 Hz, 1H), 1.93-1.51(m, 4H), 1.44-1.31 (m, 13H), 0.94-
0.89 (t, 6H). 
13C-NMR (75MHz, CDCl3-d) δ = 175.50 (COOH), 172.70 (CON), 156.11 (CO), 80.55 (>C<), 54.45 
(CH), 52.19 (CH), 34.30 (CH2), 28.40 (3CH3), 18.96 (CH2), 18.63 (CH2), 13.85 (CH3), 13.78 (CH3). 
 
 
 
34 
 
(S)-2-((S)-2-(tert-butoxycarbonylamino)pentanamido)-3-methylbutanoic acid (Boc-8, Boc-Nva-
Val) 
Boc-8 was synthesized from Boc-Nva (0.52 g, 0.24 mmol) and L-valine (0.28 g, 0.25 mmol) 
according to the procedure reported for Boc-1. Yield = 0.59 g (77%). 
MS CI+ m/z (relative intensity in %) = [M+H]+ 317 (52), 261 (73), 217 (100), 72 (53). 
1H-NMR (300MHz, CDCl3-d) δ = 9.19 (bs, 1H), 6.90-6.87 (d, J = 8.2 Hz, 1H), 5.30-5.28 (d, J = 8.3 
Hz, 1H), 4.59-4.55 (m, 1H), 4.20-4.15 (d, J = 8.0 Hz, 1H), 2.26-2.21 (m, 1H), 1.81-1.71 (m, 1H), 1.64-
1.51 (m, 1H), 1.44-1.33 (m, 11H), 0.97-0.89 (m, 9H). 
13C-NMR (75MHz, CDCl3-d) δ = 174.94 (COOH), 172.85 (CON), 156.16 (CO), 80.56 (>C<), 57.15 
(CH), 54.59 (CH), 34.21 (CH), 31.21 (CH2), 28.42 (3CH3), 19.11 (CH3), 19.00 (3CH3), 17.62 (CH2), 
13.86 (CH3). 
 
(S)-2-((S)-2-(tert-butoxycarbonylamino)pentanamido)-4-methylpentanoic acid (Boc-9, Boc-Nva-
Leu) 
Boc-9 was synthesized from Boc-Nva (0.60 g, 0.28 mmol) and L-leucine (0.36 g, 0.28 mmol) 
according to the procedure reported for Boc-1. Yield = 0.70 g (76%). 
MS CI+ m/z (relative intensity in %) = [M+H]+ 331 (15), 275 (65), 231 (100), 72 (58).  
1H-NMR (300MHz, CDCl3-d) δ = 8.24 (s, 1H), 6.86-6.83 (m, 1H), 5.31-5.29 (d, J = 6.2 Hz, 1H), 4.67-
4.60 (m, 1H), 4.17-4.14 (d, J = 8.3 Hz, 1H), 1.85-1.52 (m, 5H), 1.46-1.33 (m, 11H), 0.99-0.91 (m, 
9H). 
13C-NMR (75MHz, CDCl3-d) δ = 176.06 (COOH), 172.80 (CON), 156.19 (CO), 80.54 (>C<), 54.49 
(CH), 50.87 (CH), 41.33 (CH2), 34.28 (CH), 28.39 (3CH3), 24.90 (CH3), 23.03 (CH3), 21.90 (CH2), 
18.94 (CH2), 13.84 (CH3). 
 
(2S, 3S)-2-((S)-2-(tert-butoxycarbonylamino)pentanamido)-3-methylpentanoic acid (Boc-10, 
Boc-Nva-Ileu) 
Boc-10 was synthesized from Boc-Nva (0.50 g, 0.23 mmol) and L-isoleucine (0.30 g, 0.23 mmol|) 
according to the procedure reported for Boc-1. Yield = 0.65 g (85%). 
MS ES+ m/z (relative intensity in %) = [M+Na]+ 353 (100), 253 (48), 231 (8).  
1H-NMR (300MHz, CDCl3-d) δ = 9.73 (bs, 1H), 6.89-6.86 (d, J = 7.7 Hz, 1H), 5.27-5.24 (d, J = 7.7 
Hz, 1H), 4.63- 4.58 (m, 1H), 4.16-4.14 (d, J = 6.2 Hz, 1H), 2.00-1.89 (m, 1H), 1.83-1.69 (m, 1H), 
1.64-1.30 (m, 13H), 1.26-1.13 (m, 1H), 0.95- 0.89 (m, 9H). 
13C-NMR (75MHz, CDCl3-d) δ = 175.06 (COOH), 172.68 (CON), 156.12 (CO), 80.51 (>C<), 56.59 
(CH), 54.55 (CH), 37.81 (CH), 34.23 (CH2), 28.41 (3CH3), 25.01 (CH2), 18.99 (CH2), 15.52 (CH3), 
13.86 (CH3), 11.72 (CH3). 
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(S)-2-((S)-2-(tert-butoxycarbonylamino)pentanamido)propanoic acid (Boc-Nva-Ala) 
 
Boc-Abu-Ala was prepared from Boc-Nva (0.15 g, 0.7 mmol) and alanine (0.06 g, 0.7 mmol) 
according to the procedure reported for Boc-1. Yield = 0.14 g (67%). 
1H-NMR (300MHz, CDCl3-d) δ = 7.30 (bs, 3H), 6.98-6.96 (d, J = 8.4 Hz, 1H), 5.29-5.26 (d, J = 8.5 
Hz, 1H), 4.63-4.54 (m, 1H), 4.19-4.17 (m, 1H), 1.83-173 (m, 1H), 1.66-1.53 (m, 1H), 1.48-1.35 (m 
12H), 0.96-91 (t, J = 7.3 Hz,3H). 
1C-NMR (75MHz, CDCl3-d) δ = 175.62 (COOH), 172.61 (CON), 145.68 (CO), 79.96 (>C<), 48.33 
(CH), 34.67 (CH), 28.41 (3CH3), 18.94 (CH3), 18.19 (CH2), 18.15 (CH2), 13.85 (CH3). 
 
(S)-2-((S)-2-aminobutanamido)butanoic acid (1, Abu-Abu) 
Boc-1 (Boc-Abu-Abu) (0.65 g, 2.56 mmol) was dissolved in 20 mL of dry THF and cooled to 5-0 °C 
then 2 mL of 4M HCl in dioxane solution was added slowly. This mixture was stirred for 48 h at RT. 
Completion of reaction was monitored by the thin layer chromatography (TLC, eluent system = 20% 
MeOH in CH2Cl2 followed by ninhydrin staining). In vacuo evaporation of THF and dioxane yielded 
crude 1. The syrupy crude 1 was dissolved in 10 mL of water and extracted with diethyl ether (20 mL 
x 2) to remove the unwanted non-polar impurities. The aq. solution was neutralized with 1N NaOH 
(pH = 7-8). From this, a small amount of solution was used for crystallization (will be described in 
forthcoming section). The slow evaporation of water from the remaining solution at RT for over 2-3 
weeks afforded solid crude product, which was slurried in a minimum volume of water (5 mL) and 
filtered to remove the inorganic substances, affording the pure product 1 (Yield = 0.33 g, 77%). 
MS ES+ m/z (relative intensity in %) = [M+H]+189 (100), 41 (9).  
1H-NMR (300MHz, DMSO-d6 + D2O) δ = 4.14-4.09 (m, 1H), 3.76-3.72 (t, J = 6.2 Hz, 1H), 1.82-1.47 
(m, 4H), 0.91-0.86 (m, 6H). 
13C-NMR (75MHz, DMSO-d6 + D2O) δ = 173.75 (COO−), 169.23 (CON), 54.26 (CH), 53.62 (CH), 
25.01 (CH2), 24.65 (CH2), 10.96 (CH3), 9.33 (CH3). 
 
(S)-2-((S)-2-aminobutanamido)pentanoic acid (2, Abu-Nva) 
Compound 2 was synthesized from Boc-2 (0.75 g, 2.48 mmol) according to the procedure reported for 
1. Yield = 0.38 g (75%). 
MS ES+ m/z (relative intensity in %) = [M+H]+ 203 (100), 142 (7).  
1H-NMR (300MHz, DMSO-d6 + D2O) δ = 4.20-4.15 (m, 1H), 3.74-3.70 (t, J = 6.2 Hz, 1H), 1.82-1.21 
(m, 6H), 0.91-0.82 (m, 6H). 
13C-NMR (75MHz, DMSO-d6 + D2O) δ = 173.87 (COO−), 169.10 (CON), 53.53 (CH), 52.47 (CH), 
33.22 (CH2), 24.93 (CH2), 19.22 (CH2), 14.01 (CH3), 9.27 (CH3).  
 
 
36 
 
(S)-2-((S)-2-aminobutanamido)-3-methylbutanoic acid (3, Abu-Val) 
Compound 3 was synthesized from Boc-3 (0.75 g, 2.48 mmol) according to the procedure reported for 
1. Yield = 0.40 g (80%). 
MS ES+ m/z = [M+H]+ 203. 
1H-NMR (400MHz, DMSO-d6 + D2O) δ = 8.55-8.53 (d, J = 8.1 Hz, 1H), 8.19 (bs, 3H), 4.16- 4.13 (m, 
1H), 3.82-3.79 (t, J = 6.4 Hz, 1H), 2.13-2.04 (m, 1H), 1.81-1.69 (m, 2H), 0.90 (t, J = 7.6 Hz, 9H). 
13C-NMR (100MHz, DMSO-d6) δ = 173.30 (COO−), 169.52 (CON), 58.45 (CH), 53.64 (CH), 30.16 
(CH), 25.15 (CH2), 19.64 (CH3), 18.57 (CH3), 9.37 (CH3). 
 
(S)-2-((S)-2-aminobutanamido)-4-methylpentanoic acid (4, Abu-Leu) 
Compound 4 was synthesized from Boc-4 (0.80 g, 2.53 mmol) according to the procedure reported for 
1. Yield = 0.46 g (83%). 
MS ES+ m/z = [M+H]+ 217. 
1H-NMR (300MHz, DMSO-d6 + D2O) δ = 4.23-4.18 (m, 1H), 3.72-3.68 (t, J = 6.1 Hz, 1H), 1.79-1.48 
(m, 5H), 0.91-0.81 (m, 9 H). 
13C-NMR (75MHz, DMSO-d6 + D2O) δ = 174.47 (COO−), 169.27 (CON), 53.71 (CH), 51.31 (CH), 
40.36 (CH2), 25.02 (CH3), 24.99 (CH3), 23.48 (CH2), 21.94 (CH), 9.33 (CH3). 
 
(2S, 3S)-2-((S)-2-aminobutanamido)-3-methylpentanoic acid (5, Abu-Ileu) 
Compound 5 was synthesized from Boc-5 (0.70 g, 2.21) according to the procedure reported for 1.  
Yield = 0.41 g (85%). 
MS ES+ m/z = [M+H]+ 217. 
1H-NMR (300MHz, DMSO-d6) δ = 8.57 (d, J = 7.9 Hz, 1H), 8.18 (bs, 3H), 4.18-4.14 (m, 1H), 3.51-
3.54 (m, 1H), 1.83-1.66 (m, 3H), 1.45-1.33 (m, 1H), 1.27-1.12 (m, 1H), 0.90-0.80 (m, 9H). 
13C-NMR (75MHz, DMSO-d6) δ = 172.94 (COO−), 169.20 (CON), 57.19 (CH), 53.40 (CH), 36.55 
(CH), 25.13 (CH2), 24.98 (CH2), 16.00 (CH3), 11.79 (CH3), 9.23 (CH3). 
 
(S)-2-((S)-2-aminopentanamido)butanoic acid (6, Nva-Abu) 
Compound 6 was synthesized from Boc-6 (0.58 g, 1.92 mmol) according to the procedure reported for 
1. Yield = 0.32 g (82%). 
MS ES+ m/z = [M+H]+ 203. 
1H-NMR (300MHz, DMSO-d6 + D2O) δ = 3.82-3.77 (m, 2H), 1.74-1.60 (m, 4H), 1.41-1.23 (m, 2H), 
0.89-0.82 (m, 6H). 
13C-NMR (75MHz, DMSO-d6 + D2O) δ = 167.88 (COO−), 167.56 (CON), 54.98 (CH), 53.89 (CH), 
35.38 (CH2), 26.04 (CH2), 17.52 (CH2), 13.78 (CH3), 8.99 (CH3). 
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(S)-2-((S)-2-aminopentanamido)pentanoic acid (7, Nva-Nva)  
Compound 7 was synthesized from Boc-7 (0.56 g, 1.77 mmol) according to the procedure reported for 
1. Yield = 0.33 g (86%). 
MS ES+ m/z = [M+H]+ 217. 
1H-NMR (300MHz, DMSO-d6) δ = 8.71-8.69 (d, J = 6.2 Hz, 1H), 8.20 (bs, 3H), 4.22-4.15 (m, 1H), 
3.79-3.75 (m, 1H), 1.74-1.53 (m, 4H), 1.40-1.24 (m, 4H), 0.88-0.82 (m, 6H). 
13C-NMR (75MHz, DMSO-d6) δ = 173.52 (COO−), 169.11(CON), 52.30 (CH), 52.23 (CH), 33.58 
(CH2), 33.10 (CH2), 18.95 (CH2), 17.64 (CH2), 14.00 (CH3), 13.78 (CH3). 
 
(S)-2-((S)-2-aminopentanamido)-3-methylbutanoic acid (8, Nva-Val)  
Compound 8 was synthesized from Boc-8 (0.55 g, 1.74 mmol) according to the procedure reported for 
1. Yield = 0.30 g (80%). 
MS ES+ m/z = [M+H]+ 217.  
1H-NMR (300MHz, DMSO-d6 + D2O) δ = 4.14-4.09 (m, 1H), 3.87-3.82 (m, 2H), 2.10-1.99 (m, 1H), 
1.69-1.62 (m, 2H), 1.35-1.23 (m, 2H), 0.88-0.80 (m, 9H). 
13C-NMR (75MHz, DMSO-d6 + D2O) δ = 173.12 (COO−), 169.60 (CON), 58.28 (CH), 52.54 (CH), 
33.87 (CH2), 30.14 (CH), 19.58 (CH3), 18.52 (CH3), 17.91 (CH2), 14.20 (CH3). 
 
(S)-2-((S)-2-aminopentanamido)-4-methylpentanoic acid (9, Nva-Leu)  
Compound 9 was synthesized from Boc-9 (0.65 g, 1.96 mmol) according to the procedure reported for 
1. Yield = 0.36 g (79%). 
MS ES+ m/z = [M+H]+  231. 
1H-NMR (300MHz, DMSO-d6 + D2O) δ = 4.23-4.16 (m, 1H), 3.76-3.72 (t, J = 6.2 Hz, 1H), 1.70-1.19 
(m, 7H), 0.85-0.78 (m, 9H). 
13C-NMR (75MHz, DMSO-d6 + D2O) δ = 175.00 (COO−), 169.91 (CON), 53.17 (CH), 51.73 (CH), 
40.36 (CH2), 34.09 (CH2), 25.18 (CH), 23.61 (CH3), 22.11 (CH3), 18.17 (CH2), 14.45 (CH3). 
 
(2S, 3S)-2-((S)-2-aminopentanamido)-3-methylpentanoic acid (10, Nva-Ileu) 
Compound 10 was synthesized from Boc-10 (0.62 g, 1.87 mmol) according to the procedure reported 
for 1. Yield = 0.36 g (83%) 
MS ES+ m/z = [M+H]+ 231.  
1H-NMR (300MHz, DMSO-d6 + D2O) δ = 4.15-4.12 (m, 1H), 3.84-3.81 (m, 1H), 1.80-1.74 (m, 1H), 
1.68-1.62 (m, 2H), 1.40-1.10 (m, 4H), 0.84-0.78 (m, 9H). 
13C-NMR (75MHz, DMSO-d6 + D2O) δ = 173.23 (COO−), 169.62 (CON), 57.43 (CH), 52.65 (CH), 
36.73 (CH), 33.94 (CH2), 25.34 (CH2), 17.99 (CH2), 16.16 (CH3), 14.27 (CH3), 11.95 (CH3). 
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(S)-2-((S)-2-aminopentanamido)propanoic acid (Nva-Ala)  
Nva-Abu was prepared form Boc-Nva-Ala (0.06 g, 0.47 mmol) according to the procedure reported 
for 1. Yield = 0.7 g (79%). 
MS ES+ m/z = [M+H]+ 189. 
1H-NMR (300MHz, DMSO-d6) δ = δ 8.82-8.80 (d, J = 6.9 Hz, 1H), 8.33- 8.11 (m, 3H), 4.26-4.16 (m, 
1H), 3.77- 3.73 (m, 1H), 1.69-1.63 (m, 2H), 1.32-1.24 (m, 5H), 0.86-81 (t, J = 7.3 Hz, 3H). 
13C-NMR (75MHz, DMSO-d6) δ = 174.47 (COO−), 169.25 (CON), 52.81(CH), 48.59 (CH), 40.41, 
33.96 (CH2), 18.07 (CH3), 17.58 (CH2), 14.45 (CH3). 
 
Crystallization of dipeptides 1-10: X-ray quality crystals of dipeptides 1-10 were obtained by a 
gel crystallization diffusion method. The neutralized aq. solution (100 μL) of each dipeptide was 
mixed with tetramethoxysilane (50 μL) in different small tubes and shaken vigorously for about 1 min. 
The tubes were then sealed with parafilm and the seal pierced by a sharp needle to make 3-4 holes. 
These tubes were placed in the air tight bottles containing acetonitrile (2-3 ml) allowing slow diffusion 
into the tubes. After 3-4 days the crystals of 1-10 were seen as colourless needles in the respective 
tubes. 
 
Synthesis of Abu-Phe and Nva-Phe 
 
(S)-2-((S)-2-(tert-butoxycarbonylamino)butanamido)-3-phenylpropanoic acid (Boc-Abu-Phe) 
Boc-Abu-Phe was synthesized from 2a (0.27 g, 1.33 mmol) and L-Phenylalanine (0.22 g, 1.33 mmol) 
according to the procedure reported for 3a. Yield = 0.20 g (43%). 
CI+ m/z (relative intensity in %) = [M+H]+ 351 (60), 251 (100).  
1H-NMR (300MHz, CDCl3-d), δ = 7.42 (bs, 2H), 7.32-7.12 (m, 5H), 6.85-6.83 (d, 1H), 5.23-5.20 (d, 
1H), 4.14-4.06 (m, 1H), 3.24-3.18 (m, 1H), 3.07-3.00 (m, 1H), 1.85-1.71 (m, 1H), 1.59-1.55 (m, 1H), 
1.46 (s, 9H), 0.92-0.87 (t, J = 6.3 Hz, 3H).  
13C-NMR (75MHz, CDCl3-d), δ = 174.28 (COO−), 172.47 (CON), 159.47 (CO), 136.27 (Ph C), 
129.81 (Ph C), 128.90 (Ph C), 127.43 (Ph C), 80.50 (>C<), 56.08 (CH), 53.59 (CH), 37.87 (CH2), 
28.69 (3CH3), 26.06 (CH2), 10.26 (CH3). 
 
(S)-2-((S)-2-aminobutanamido)-3-phenylpropanoic acid (Abu-Phe) 
Abu-Phe was prepared from Boc-Abu-Phe (0.20 g, 0.57 mmol) according to the procedure reported 
for 1. Yield = 0.12 g (84%). 
 MS ES+ m/z = [M+H]+ 251.  
1H-NMR (300MHz, DMSO-d6 + D2O), δ = 7.23-7.15 (m, 5H), 4.42-4.06 (m, 2H), 3.10-3.03 (m, 2H), 
2.03-1.90 (m, 1H), 1.66-1.53 (m, 1H), 0.81-0.78 (t, J = 6.2 Hz, 3H). 
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13C-NMR (75MHz, DMSO-d6 + D2O), δ = 160.70 (COO−), 164.25 (CON), 136.23 (Ph C), 130.50 (Ph 
C), 128.49 (Ph C), 53.76 (CH), 52.56 (CH), 35.35 (CH2), 29.07 (CH2), 11.49. (CH3). 
(S)-2-((S)-2-(tert-butoxycarbonylamino)pentanamido)-3-phenylpropanoic acid (Boc-Nva-Phe) 
Boc-Nva-Phe was synthesized from Boc-Nva (0.11 g, 0.50 mmol) and L-phenylalanine (0.85 g, 0.51 
mmol) according to the procedure reported for Boc-1. Yield = 0.12 g (63%). 
MS ES+ m/z (relative intensity in %) = [M+H]+ 365 (58), 265 (100). 
1H-NMR (300MHz, CDCl3-d), δ = 7.77 (bs, 1H), 7.28-7.15 (m, 5H), 6.83-6.81 (d, J = 7.5 Hz, 1H), 
5.15-5.12 (d, J = 8.4 Hz, 1H), 4.87-4.81 (m, 1H), 4.15 (m, 1H) 3.24-3.16 (m, 1H), 3.06-2.99 (m, 1H), 
1.75-1.66 (m, 1H), 1.46 (s, 9H), 1.38-1.24 (m, 2H), 0.92-0.87 (t, J = 7.2 Hz, 3H)  
13C-NMR (75MHz, CDCl3-d), δ = 174.39 (COO−), 172.66 (CON), 156.26 (CO), 136.29 (Ph C), 
129.83 (Ph C), 128.88 (Ph C), 127.45 (Ph C), 77.61 (>C<), 54.68 (CH), 53.63 (CH), 37.85 (CH2), 
34.82 (CH2), 28.68 (3CH3), 19.15 (CH2), 14.06 (CH3). 
 
(S)-2-((S)-2-aminopentanamido)-3-phenylpropanoic acid (Nva-Phe) 
Nva-Phe was prepared from Boc-Nva-Phe (0.12 g, 0.33 mmol) according to the procedure reported 
for 1. Yield = 0.06 g, (70%).  
MS ES+ m/z = [M+H]+ 265.  
1H NMR (300 MHz, DMSO-d6) δ = 8.84-8.81 (d, J = 9 Hz, 1H), 8.25-8.10 (m, 3H), 7.34-7.14 (m, 
5H), 4.48-4.40 (m, 1H), 3.76-3.70 (m, 1H), 3.09-3.03 (m, 1H), 2.96-2.88 (m, 1H), 1.69-1.65 (m, 2H), 
1.33-1.27 (m, 2H), 0.86-0.81 (t, J = 7.3 Hz, 3H). 
13C-NMR (75MHz, DMSO-d6) δ = 173.24 (COO−), 169.67 (CON), 137.97 (Ph C), 129.88 (Ph C), 
129.19 (Ph C), 127.49 (Ph C), 54.78 (CH), 52.80 (CH), 37.16 (CH2), 34.04 (CH2), 18.07 (CH2), 14.45. 
(CH3). 
 
Crystallization: Slow evaporation of water from a neutralized solution at RT over three weeks 
afforded the colourless crystals of Nva-Phe, but Abu-Phe remained as powder. 
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b) Dipeptides from Abu, Nva, Pro and Ser amino acids 
 
 
Scheme-2: Synthetic schemes for the Abu-Ser, Nva-Ser and Pro-Ser molecules.  
Reagents and conditions: a) Benzylchloroformate, 2N NaOH, H2O; b) i)DCC/ CH2Cl2/ N-hydroxysuccin- 
imide ii) NaHCO3, THF/acetone, H2O, Bn-O-Ser; c) THF, HCl; d) i) Pd/C, H2, HCl ii) NaOH. 
 
Synthesis of (S)-3-(benzyloxy)-2-((S)-2-((tert-butoxycarbonyl) amino) butanamido) propanoic 
acid (Boc-Abu-Bn-O-Ser) 
Boc-Abu-Bn-O-Ser was prepared from Boc-L-2-aminobutyric acid (Boc-Abu, 0.50 g, 2.46 mmol), 
NHS (0.31 g, 2.70 mmol) and DCC (0.56 g, 2.70 mmol) according to the procedure reported for Boc-
1, however, THF was used instead of acetone (as in earlier preparations) for the coupling of O-benzyl-
L-serine (Bn-O-Ser, 0.48 g, 2.46 mmol) at C-terminal. Yield = 0.90 g (95%). 
1H-NMR (200MHz, DMSO-d6), δ = 13.77 (bs, 1 H), 8.02-7.99 (d, J = 9.0 Hz, 1H), 7.38-7.25 (m, 5H), 
6.86-6.81 (d, J = 9.0 Hz, 1H), 4.42-4.54 (m, 3 H) 3.98-3.87 (m, 1 H) 3.79-3.71 (m, 1H), 3.64-3.68 (m, 
1 H), 1.73-1.45 (m, 2 H), 1.36 (s, 9 H), 0.87-0.84 (t, J = 7.2 Hz, 3H).  
13C-NMR (50MHz, DMSO-d6), δ = 172.90 (COOH), 172.28 (CO), 156.17 (CO), 138.88 (Ph C), 
129.04 (Ph C), 128.34 (Ph C), 128.30 (Ph C), 78.85 (>C<), 73.04 (O-CH2), 70.41 (CH2-O), 56.30 
(CH), 53.14 (CH), 29.05 (3CH3), 26.16 (-CH2), 11.18 (-CH3). 
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(S)-2-((S)-2-ammoniobutanamido)-3-hydroxypropanoate (Abu-Ser) 
Abu-Ser was prepared by dissolving Boc-Abu-Bn-O-Ser (0.70 g) in dry THF (25 mL) and 2 mL of 4 
M HCl in dioxane was added slowly at RT. The reaction mixture was stirred at RT for 48 h (TLC, 
eluent system MeOH:CH2Cl2 (1:9) and ninhydrin spray). Evaporation of the reaction solvents under 
reduced pressure afforded the product (0.50 g) as HCl salt, which was redissolved in fresh THF (30 
mL) and 10% Pd/C (0.200 mg) was added. The RBF was then pressurized with a balloon containing 
hydrogen gas. Reaction mixture was continuously stirred for overnight and monitored by TLC (1:4, 
MeOH:CH2Cl2). Filtration of reaction slurry through the celite pad afforded sticky substance (Pd/C + 
product), which was rinsed with fresh THF (10 mL). The residual sticky Pd/C was slurried in water 
(10 mL) and filtered through celite. The filtrate was made basic with 2N NaOH (pH = 7-8).  
Crystallization of Abu-Ser  
The fine X-ray quality crystals of L-Abu-L-Ser were grown by adding few drops of DMF into the 
above aq. solution and slow evaporation of solvents at RT afforded substantial amount of crystalline 
Abu-Ser (0.28 g, 78%).   
MS ES+ m/z = [M+H]+ 191. 
NMR data 1H-NMR (200MHz, DMSO-d6 + D2O), δ = 4.29-4.26 (m, 1 H), 3.82-3.63 (m, 3 H), 1.77 (s, 
2 H), 0.94-0.87 (m, 3H);  
13C-NMR (50MHz, DMSO-d6 + D2O), δ = 171.20 (COO−), 168.43(CO), 60.97(CH), 54.98 (CH2), 
52.88 (CH), 24.30 (CH2), 8.76 (CH3). 
 
(S)-2-(benzyloxycarbonylamino)pentanoic acid (Z-Nva) 
Z-Nva was prepared from L-norvaline (Nva, 0.70 g, 6.0 mmol) and benzylchloroformate (CBz- or Z-
chloride, 1.02 g, 6.0 mmol) as per the literature procedure for Z-D-norvaline.1 Yield = 1.40 g (79%). 
1H-NMR (300MHz, CDCl3-d), δ = 10.90 (s, 1H), 7.41-7.30 (m, 5H), 5.37-5.34 (d, J = 9.2 Hz, 1H), 
5.20-5.14 (m, 2H), 4.47-4.42 (m, 1H), 1.88-1.67 (m, 2H), 1.47-1.39 (m, 2H), 0.99-0.94 (t, J = 7.3 Hz, 
3H). 
13C-NMR (75MHz, CDCl3-d), δ = 174.91(COOH), 157.03 (CO), 137.88 (Ph C), 129.18 (Ph C), 
128.63 (Ph C), 128.54 (Ph C), 66.21 (CH2), 54.40 (CH), 33.70 (CH2), 19.61 (CH2), 14.27 (CH3). 
(S)-3-(benzyloxy)-2-((S)-2-(benzyloxycarbonylamino)pentanamido)propanoic acid (Z-Nva-Bn-O-
Ser) 
Z-Nva-Bn-O-Ser was prepared from Z-Nva (0.50 g, 2.0 mmol) and (S)-2-amino-3-(benzyloxy)-
propanoic acid (Bn-O-Ser, 0.39 g, 2.0 mmol), according to the procedure reported for Boc-1.  
Yield = 0.75 g (88%). 
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1H-NMR (300MHz, DMSO-d6), δ = 12.75 (m, 1H), 8.15 (d, J = 7.9 Hz, 1H), 7.47-7.21 (m, 11H), 5.03 
(s, 2H), 4.51-4.45 (m, 3H), 4.13-4.09 (m, 1H), 3.76-3.64 (m, 2H), 1.70-1.41 (m, 2H), 1.43-1.20 (m, 
2H), 0.85 (t, J = 7.2 Hz, 3H). 
13C-NMR (75MHz, DMSO-d6), δ = 173.02 (COOH), 172.25 (CON), 156.76 (CO), 138.85 (Ph C), 
137.91(Ph C), 129.18 (Ph C), 129.05 (Ph C), 128.60 (Ph C), 128.48 (Ph C), 128.34 (Ph C), 128.32 (Ph 
C), 73.04 (CH2),  70.28 (CH2), 66.19 (CH2),  55.08 (CH), 53.13 (CH), 35.00 (CH2), 19.46 (CH2), 14.49 
(CH3). 
 
(S)-2-((S)-2-aminopentanamido)-3-hydroxypropanoic acid (Nva-Ser) 
Z-Nva-Bn-O-Ser (0.46 g, 1.1 mmol) was dissolved in 20 mL of dry THF and cooled between 5 - 0 °C. 
10% wet Pd/C (0.2 g) was added to the solution followed by the addition of 4M HCl in dioxane (0.5 
mL). The reaction mixture was stirred for 48 h at RT (TLC, MeOH:CH2Cl2 (1:4) and ninhydrin 
staining). THF was decanted and the sticky substance (Pd/C + product) washed with fresh THF (5 
mL). The residual Pd/C was then slurried in water (5 mL) to dissolve the water soluble product and 
filtered through a celite pad. Evaporation of water filtrate was carried out under reduced pressure to 
yield syrupy product (Nva-Ser.HCl) (0.20 g, 77%). The syrupy product was again dissolved in fresh 
water and then neutralized the solution with aq. 1N NaOH (pH = 7-8). The basified solution was 
further used for the crystallization experiments.  
MS ES+ m/z = [M+H]+ 205. 
1H-NMR (200MHz, DMSO-d6 + D2O), δ = 4.33-4.32 (t, J = 4.7 Hz, 1H), 3.87-3.64 (m, 3H), 1.75-1.62 
(m, 2H), 1.39-1.26 (m, 2H), 0.87-0.82 (t, J = 6.3 Hz, 3H) 
13C-NMR (75MHz, DMSO-d6), δ = 171.12 (COO−), 169.56 (CON), 61.88 (O-CH2), 55.84 (CH), 52.72 
(CH), 34.07 (CH2), 18.21 (CH2), 14.56 (CH3).  
 
(S)-1-(benzyloxycarbonyl)pyrrolidine-2-carboxylic acid (Z-Pro-Bn-O-Ser) 
Z-Pro-Bn-O-Ser was prepared from Z-proline (0.70 g, 4.00 mmol) and Bn-O-Ser, NHS (0.47 g, 4.00 
mmol) according to the procedure reported for Boc-1 (scheme 1). Yield = 0.74 g (61%). 
MS ES− m/z (relative intensity in %) = [(2xM)-H]− 851 (52), [M−H]− 425 (100), 317 (60), 165 (8).  
1H-NMR (300MHz, DMSO-d6), δ = 12.78 (bs, 1H), 8.30-8.22 (m, 1H), 7.38-7.26 (m, 10H), 5.12-4.94 
(m, 2H), 4.52-4.35 (m, 4H), 3.81-3.32 (m, 4H), 2.22-2.02 (m, 1H), 1.90-1.76 (m, 3H).  
13C-NMR (75MHz, DMSO-d6), δ = 172.33 (2 CO), 154.64 (Z-CO), 138.82 (Ph C), 137.83 (Ph C), 
129.04 (Ph C), 128.31 (Ph C), 127.79 (Ph C), 73.06 (CH2), 70.37 (CH2), 66.67 (CH2), 66.55 (CH), 
59.80 (CH), 47.99 (CH2), 31.95 (CH2), 23.81 (CH2). 
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(S)-3-hydroxy-2-((S)-pyrrolidine-2-carboxamido)propanoic acid (Pro-Ser) 
Pro-Ser was prepared from Z-Pro-Bn-O-Ser (0.40 g) by the procedure reported for Nva-Ser.  
Yield = 0.17 g (88%).  
MS ES+ m/z (relative intensity in %) = [M+H]+ 203 (100), 70 (7). 
H-NMR (200MHz, DMSO-d6) = δ 10.33-10.15 (m, 1H), 8.99-8.95 (d, 1H, J = 8 Hz), 8.49-8.47 (s, 
1H), 4.32-4.20 (m, 2H), 3.77-3.62 (m, 2H), 3.22-3.14 (m, 2H), 2.41-2.20 (m, 1H), 1.93-1.72 (m, 3H);  
13C-NMR (50MHz, DMSO-d6), δ = 171.21 (CO), 168.33 (COO−), 60.94 (CH), 58.53 (CH2), 55.17 
(CH), 45.64 (CH2), 29.72 (CH2), 23.53 (CH2).  
 
Crystallization of Pro-Ser 
X-ray quality crystals of Pro-Ser were obtained by using the similar gel crystallization method used  
for the dipeptides 1-10 (see page 38).  
 
Reference:  
 
 (1) Oka, T.; Yasusa, T.; Ando, T.; Watanabe, M.; Yoneda, F.; Ishida, T.; Knoll, J. Bioorg. Med.   
        Chem. 2001, 9, 1213-1219. 
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Chapter 2 
Guanidiniun-carboxylate Based Supramolecular Complexes 
2.1 The Guanidine Subgroup and Molecular Recognition  
The guanidine moiety found in biomolecules such as arginine, an amino acid residue of 
various enzymes or proteins, and guanine, a nucleic acid base of RNA and DNA. It has a 
natural tendency to form charge-assisted hydrogen bonds with the carboxylate or phosphate 
anions of protein or nucleic acids, respectively.1-4 In living beings, such definitive 
intermolecular interactions are very crucial for the bio-chemical modifications, for example; 
the nitric oxide synthesis by enzymatic catalysis, electron transfer reactions in respiration 
process and RNA-protein recognition etc. 4-8  
 
Figure 2.1.1: L-arginine and guanine, guanidine precursors in the biological macromolecules.1-4 
Inspired by naturally occurring specific interactions there have been numerous 
research efforts in the field of bio-organic chemistry to prepare abiotic receptors based on the 
guanidinium structures9 (Fig. 2.1.2). As receptors, the cationic guanidiniums were designed to 
interact non-covalently and selectively with various oxoanions, such as carboxylate, 
carbonate, sulfonate, phosphonate and nitro groups, to generate host-guest complexes in the 
solids and solutions.4,10-16,17-29     
 
Figure 2.1.2: The abiotic receptor21 structures a) a substituted guanidine derivative and b) rigid-
bicyclic guanidine system for high selectivity.  
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2.2 Guanidine in Crystal Engineering  
 
Unsubstituted guanidine is a versatile molecule in organic chemistry, acting as base (pKa = 
13.6) or reagent.30 It readily forms a guanidinium cation with various organic protic acids 
(carboxylic, sulfonic, phosphonic acids and boric acid31) or a co-crystal with the nitro 
compounds.32 The formed cation is stable and remains protonated over a wide pH range. 
Specially, structural features such as low molecular weight, planar conformation and three-
fold molecular symmetry (triangular geometry)33 have made the guanidinium group a favorite 
for use in research. It has been extensively used building block in crystal engineering to 
prepare novel supramolecular assemblies.34-51  
The sulfonate (sulfate) and phosphonate (phosphate) groups are the anions with 
tetrahedral geometry and they form guanidinium complexes with different structural 
properties.52 By contrast, the carboxylate group has planar geometry; moreover, carboxylic 
acid is a very common functional group in biomolecules and also a well exploited group in 
the suprmolecular chemistry.53 Therefore, the study of carboxylate and guanidinium related 
complexes was the main topic of this investigation.  
Usually, when guanidine abstracts a proton from a carboxylic group, the guanidinium 
ion interacts in the syn direction of the O atoms of the carboxylate group and forms two 
parallel charge-assisted (+N–H···O–) hydrogen bonds to generate a stable cyclic association  
i. e. ଶଶሺͺሻ motif [Fig. 2.1.1].  
  
Figure 2.2.1: A guanidinium-carboxylate complex showing formation of the hydrogen-bonded ଶଶሺͺሻ 
motif in syn direction of carboxylate O atoms. 
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2.3 Guanidinium-Carboxylate Complexes: CSD Survey and Specific Interactions 
Though the guanidinum-carboxylate interactions are directive, it is very rare to see three 
carboxyl/carboxylate (or carbonate) counterions interacting evenly with a single guanidinium 
cation by accepting its six hydrogen atoms to generate three independent ଶଶሺͺሻ motifs [as 
shown in Fig. 2.3.1 (a, b)]. In 66 structures with guanidinium ions and carboxylates retrieved 
from the CSD, this pattern was found only nine times (Table 2.3). The fraction forming just 
one ଶଶሺͺሻ motif (34 structures) is comparatively higher than two- and three-ଶଶሺͺሻ motif 
formers (Table 2.3). Surprisingly, in spite the high propensity for ଶଶሺͺሻ motif formation 
between guanidinium and carboxylate, several structures do not show these H-bonded 
interactions at all (Table 2.3) (Fig. 2.3.2 a, b).  
Table 2.3: A CSD survey of guanidinium-carboxylate organic complexes forming ଶଶሺͺሻ   
                  motifs (Total 65 hits) 
 
Three, ଶଶሺͺሻ motifs 
(9 structures) 
Two, ଶଶሺͺሻ motifs 
(12 structures) 
One, ଶଶሺͺሻ motif 
(34 structures) 
Zero, ଶଶሺͺሻ motif 
(10 structures) 
QIFFIU, 
QIFFOA36, 
DOTWOZ40, 
TAVFOM, 
TAVFUS51, 
JOGTIJ, 
JOGTEF31, 
GUANCB54 and 
TUTGEV55. 
SEWXAU,  
SEWXEY, 
YEYWUV43,  
JOGTUV,  
JOGVAD31,  
TUTFIY,  
TUTFOE,  
TUTGIZ,  
TUTGAR55, 
KABKEF56, 
XUVRUB57 and  
DUJKID58. 
 
ANEPAL, 
ANENOX, 
ANENUD01, 
ANENUD, BOJFEM, 
DADBEQ, 
DEHSAK10, 
DUFDIR10, 
DUFDOX10, 
DUMPUW, 
ETIZOW, EVASAW, 
FEDPUA, FOVMEI, 
GIHCIK, GUHOXM, 
GUPICL10, 
GUPMYL, 
HUTNEP, IWIRAH, 
IZIJEH, JEWCUK, 
NOTPAN, PACDEC, 
PAGDIG, PUJDAA, 
TEVRAO, 
UJOCOM,VOTMEN, 
XAGFAM, 
YEYMEN, YEJZAO, 
YUVRUB and 
ZAYHEO. 
BUDXII, 
GADOXP10, 
GUPMEL, 
KIKKEV, 
LABZAP, 
MENPOL, 
SIDMOH, 
UFALET59 
UJOCUS and 
UJODAZ. 
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Figure 2.3.1: The representative guanidinum-carboxylate structures showing formation of different 
interactions; a) and b) show the structures with three ଶଶሺͺሻ motifs in a guanidinium-carboxylate 
recognition complex in syn direction of O atoms of the carboxylate groups (Refcodes QIFFIU and 
GUANCB).36,54 c) A guanidinium cation forming two ଶଶሺͺሻ motifs while the remaining two H atoms 
of the guanidinium donor interact with carboxylates in different directions (KABKEF),56 d) and e) A 
guanidinium cation forming a single ଶଶሺͺሻ motif, the rest of the guanidinium hydrogen atoms being 
engaged in bifurcated ଶଵሺ͸ሻ motifs (GIHCIK and DUFDOX10).60,61 The light blue color represents 
the ଶଶሺͺሻ motifs while light red color represents ଶଵሺ͸ሻ motifs. The hydrogen bonds are shown by 
dotted lines.  
 
Figure 2.3.2: a) A guanidinium-carboxylate complex without any ଶଶሺͺሻ H-bonding motifs 
(KIKKEV62) instead forms bifurcated ଶଵሺ͸ሻ hydrogen bonds either with the O atom of carboxylate 
group (light-red color) or with the co-crytallized water molecule (light grey color). b) Random H 
bonding networks formed by three carboxylates and a guanidinium cation along with co-crystallized 
water molecules (Refcode; UJODAZ).63  
In general, the carboxylate groups in zwitterionic structures easily form more than two 
hydrogen bonds, such as in small peptides.64,65 Similarly, when a ଶଶሺͺሻ motif is formed by 
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one carboxylate group with a guandinium group, the other carboxylate groups remain in the 
proximity by accepting a hydrogen atom of guanidinium with a normal or bifurcated manner 
(Fig. 2.3.1, d). Also, if the mono-, di- or tricarboxylates interact with the guanidinium group 
through syn lone pairs of carboxylate O atoms to form ଶଶሺͺሻ, concurrently the anti lone pairs 
of carboxylate O atoms become accessible to the available donors (water or guanidinium 
cation etc) (Fig. 2.3.2). By these multiple hydrogen bonds formation, the guanidinium and 
carboxylate groups mutually satisfy their capacity of non-covalent interactions in their 
complexes.  
Therefore, in the cases of guanidinium-carboxylates forming two, one and zero ଶଶሺͺሻ 
motifs, we assume that in addition to the unpredictable steric and structural properties of the 
molecules with carboxylic acid functionality, there could be two obvious reasons for such 
irregular H-bonding patterns: i) guanidinium ion as a multiple H atom (six H atoms) donor 
and ii) the additional interactions (more than two) of carboxylate O atoms through the lone 
pairs of electrons upon charge-assisted complex formation. These observations show that 
when a guanidinium ion and carboxylate group forms single ଶଶሺͺሻ H-bonded motif, their 
zwitterionic adduct simultaneously interacts with other donors or acceptors and ultimately 
forms two- or three-dimensional closely packed networks. 
2.4 Effective Strategy to Utilize the Guanidinium Subgroup in Crystalline Materials  
2.4.1 Selection of Guanidine Derivative  
To exploit a guanidinium moiety as a building block in crystal engineering in the present 
work we directed attention to manipulating its H bond forming capacity. Hence we decided to 
introduce a guanidine derivative that could interact with just a single carboxylate group to 
form one ଶଶሺͺሻ motif. We considered that these efforts would minimize the structural 
complications we have been noticed in earlier structures with native guanidine. Furthermore, 
through this restrictive approach we foresaw the diversion of carboxylate O atom anti lone 
pairs to interact with a single donor at a time.  In the absence of any other donors (Fig. 
2.4.1.1) co-crystallized water molecules could fill this hole. Thus, the resulting complex 
would include two water molecules per guanidinium-carboxylate in a crystal. Since water is 
dynamic and it has the ability to form different clusters, chains and tapes in crystals through 
co-operative hydrogen bonding, here we expected that the water molecules interacting directly 
with the guanidinium-carboxylate complex may also interact with additional molecules in the 
process of network building in crystals. The idea to facilitate water incorporation in crystals of 
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such complexes was a deliberate move, because the various water networks in different 
molecular crystals lattices are of the utmost interest to the theoretical, biological and 
nanomaterial sciences.66-84 
 
Figure 2.4.1.1: A modified and representative design of the guanidinium-carboxylate complex to be 
used in this work, where only a pair of H atoms of the guanidinium ion is interacting with the two O 
atoms of the carboxylate group in syn direction and directs the anti-lone pairs of carboxylate O atoms 
to interact freely with the water molecules. Other two pairs of H atoms are blocked by (R) 
substitutions.  
To begin with, the selection of an appropriate guanidine derivative was a major concern 
before actual demonstrations. Clearly, in the required molecule four out of six guanidinium H 
atoms should be replaced by alkyl (R) group (R = methyl or ethyl etc) (Fig. 2.4.1.1). 
Guanidinium derivatives were however not available commercially and also quite challenging 
to prepare in the laboratory. 
A few of di-N,N’ and tri-N,N’,N’’ substituted guanidine derivatives (Fig. 2.4.1.2. b, c and d ) 
were cocrystallized with the carboxylic acids, but the non-planar geometry and accessible H-
atoms other than involved in ଶଶሺͺሻ of cations generate irregular H-bonded networks 
(HOFDAH, HOFDEL, POVDUZ, SANQUU,85-88 EWODOK, EWODUQ, EWOFAY,89 
PAXJIJ, YEPBAX, YEPBEB, YEPBIF, YEPBOL90,91). Thus these derivatives were also not 
the suitable options to incorporate in this design as they did not show the formation of ଶଶሺͺሻ 
motifs. 
Finally we found that a rigid guanidinium derivative 1, 5, 7-Triazabicyclo[4.4.0]dec-5-
ene (TBD, pKa = 13.6) (Fig. 2.4.1.2.e) was an appropriate molecule. It has a guanidine group 
locked in rigid cyclic conformation, which selectively can donate only two H-atoms in its 
cationic state. The TBD molecule is often used as a building block in co-ordination 
chemistry,92,93 as a base or catalyst in synthetic organic chemistry,94-97 but it has very rarely 
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been exploited as a building block in crystal engineering.98-105 Hence we decided to explore 
the versatility of TBD in our supramolecular synthetic strategy.  
 
Figure 2.4.1.2: a) A guanidinium cation with six H atoms. b) di-phenyl substituted guanidinium. c) 
tri-phenyl substituted guanidinium. d) tri-isopropyl guanidinium. e) TBD a rigid guanidinium 
derivative. In b), c) and d) H atoms not involved in ଶଶሺͺሻ motif are shown in red. 
2.4.2 Di-guanidinium Ligand: Two Better than One 
A compound with more than one gaunidinium group in a single molecule such as a 
hypothetical ditopic-guanidinium system (I) could be a linker between two carboxylates with 
two ଶଶሺͺሻ motifs in a guanidinium-carboxylate related complex, thus ultimately could 
interact with four water molecules (1:2:4 complex) of hydration in a complex as shown in 
strategy (A) (Fig. 2.4.2). 
 
Figure 2.4.2: A strategy (A) showing ditopic guanidinium-carboxylate complex for enhanced 
hydration in crystals. 
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2.4.3 Organic Frameworks from I 
Presently, the preparations of metal-organic frameworks (MOFs) is a hot topic in chemistry 
due to their strong, attractive and very useful networks.106 In MOFs metal ions or metal 
clusters function as a node and the organic ligands as node connections. By the same 
principle, di-topic guanidinium I could be used effectively as an organic linker with different 
carboxylic acids (nodes) to obtain linear, 2D and 3D networks as shown in Fig. 2.4.3.   
 
Figure 2.4.3: Designs showing preparation of purely organic a) 1D or 0D, b) 2D and c) 3D 
frameworks from hypothetical versatile di-topic guandinium (I) and various dicarboxylic acid 
molecules. 
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Unfortunately, molecule I is neither available commercially nor synthetically easy to prepare, 
but in the future efforts could be directed towards the synthesis of I. Hence, the possibility of 
employing compound I in the present study was ruled out.  
Alternatively, we planned to synthesize another molecule II, in which the ring linking (X = -
O- or -CH2-) between the two rings of I is replaced by an aromatic group. 
 
In order to check the feasibility of desired product formation, the following reactions (Fig. 
2.4.5) were attempted, unfortunately the crucial cyclization step107 failed to produce the mono 
guanidinium derivative III, instead yielding the unreacted reagents.  
 
Figure 2.4.5: Reaction scheme for attempted synthesis of molecule III.  
Therefore, without wasting time on molecule II, we abandoned further investigations in this 
direction, but such types of molecules would have great impact as an organic ligand in the 
preparation of entirely organic supramolecular materials, hence in the future further synthetic 
efforts would be worthwhile.  
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2.5 Guanidine Derivative (TBD) and Dicarboxylic acids in Crystal Engineering  
As the bi-guanidine derivatives I and II were unavailable, we decided to use TBD, with 
dicarboxylic acids (as linkers between the TBD molecules) in an initial screening to generate 
two ଶଶሺͺሻ in a complex. In fact this strategy (B, Fig. 2.5.1) also provides the same sites of 
interactions for the equivalent number of water molecules as earlier (A, Fig. 2.4.3), however, 
here the binding order, orientation and the molecular ratio (2:1:4) of the components is 
different (Fig. 2.5.1). The advantage of strategy B is that availability of a wide variety of 
dicarboxylic acids as linkers that can produce distinct networks.  
 
Figure 2.5.1: The alternative strategy B showing interactions of four water molecules with 
guanidinium-carboxylate and formation of the 2:1:4 complexes.  
2.6 Experimental Section  
2.6.1 Materials and Crystals Synthesis  
In order to validate our hypothesis of the limited H-bonding ability of guanidinium-
carboxylate complex and its H bonds formation with the water molecules through anti lone 
pairs of carboxylate O atoms, a series of dicarboxylic acids and a monocarboxylic acid with a 
special structural feature (such as glycolic acid) have been screened in combination with 
TBD.  
A total of 15 carboxylic acids were purchased from Sigma-Aldrich together with TBD 
and used without further purification. Structural property-wise these carboxylic acids are 
different from one another; hence we categorized them into two groups di- and 
monocarboxylic acids. 
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2.6.2. Dicarboxylic Acids and TBD Complexes  
In this group 13 dicarboxylic acids of different linkers were studied with TBD. On the basis of 
linker nature, this group is again divided into three subgroups.  
2.6.2.1 Bi-aromatic dicarboxylic acids and TBD  
2.6.2.2 Aliphatic saturated/unsaturated dicarboxylic acids and TBD 
2.6.2.3 Aromatic dicarboxylic acids and TBD 
2.6.2.1 Bi-aromatic Dicarboxylic Acids and TBD 
Two dicarboxylic acids with extended aromaticity were used: biphenyl-4,4'-dicarboxylic acid 
(BPHA) and 2,2'-bipyridine-5,5'-dicarboxylic acid (BPDA) (Fig. 2.6.2.1a).  
 
Figure 2.6.2.1a: TBD and di-aromatic carboxylic acids studied here for the 2:1:4 crystalline complex 
formations.  
Synthesis of complex BPHA : 2TBD (BHT): The BPHA (24 mg, 0.1 mmol) was mixed 
with TBD (28 mg, 0.2 mmol) for proton exchange in water (3 mL) to generate the 2:1:4 solid-
state complex (BHT). A few drops of N,N-dimthylformaamide (DMF) were also added to the 
mixtures to assure a homogeneous and clear reaction solution. The purpose of DMF addition 
was also to prevent the complete dehydration during the course of slow solvent evaporation 
process while obtaining the X-ray diffraction quality single crystals. However, after four 
weeks, this mixture was afforded an amorphous powder. 
Synthesis of complex BPDA : 2TBD (Type I): A 2:1 complex between BPDA and TBD 
here referred as Type I and was prepared using BPDA (24 mg, 0.1 mmol) and TBD (28 mg, 
0.2 mmol) by the same method as described above for BPHA and TBD.  This complex 
afforded colorless, fragile and air-sensitive crystals.  
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Synthesis of complex BPDA:1TBD (This complex also referred as Type II): After 
obtaining Type I crystals, another experiment was set to obtain a 2:2:4 complex, an extended 
complex of TBD and BPDA (Fig. 2.6.2.1b)  For this, BPDA (24 mg, 0.1 mmol) and TBD (14 
mg, 0.1 mmol) were mixed in water (3 mL) and few drops of DMF at room temperature. Slow 
evaporation of the solvents afforded colorless crystals of Type II. Unlike Type I, the Type II 
crystals were robust and stable.  
 
Figure 2.6.2.1b: A schematic representation showing an expected 2:2:4 complex from TBD and 
BPDA. 
2.6.2.2 Aliphatic Saturated/Unsaturated Dicarboxylic Acids and TBD  
This subgroup constitutes seven carboxylic acids with different length aliphatic linkers 
bridging two carboxylic groups. These were either saturated (oxalic, malonic, succinic, 
glutaric and adipic acid) or unsaturated (maleic and fumaric acids) in nature (Fig. 2.6.2.2).  
 Figure 2.6.2.2: Aliphatic saturated and unsaturated dicarboxylic acids used for 2:1:4 complex 
formation with TBD. 
Preparation of complexes: Each dicarboxylic acid (0.1 mmol) was mixed with TBD (0.2 
mmol) and dissolved in 2 mL of water at RT before stirring for 10 min. They were left 
standing for 3-4 weeks whereupon slow evaporation of solvent afforded the complexes:  
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Only oxalic acid (OxT), glutaric acid (GuT), adipic acid (AdT) and fumaric acid (FuT) 
resulted into crystals while rest of the acids did not form crystals with TBD.  
2.6.2.3 Aromatic Dicarboxylic Acids and TBD 
The linker of the dicarboxylic acids in this subgroup is a six-membered aromatic group such 
as phenyl or pyridine and two carboxyl groups being attached at different positions on the 
rings with respect to each other. These acids are terphthalic, isphthalic, phthalic and pyridine-
3,5-dicarboxylic acid (Fig. 2.6.2.3).  
Figure 2.6.2.3: Aromatic dicarboxylic acids tested with TBD for 2:1:4 complex formation. 
Preparation of complexes: Each carboxylic acid and TBD in 1:2 stoichiometries were 
combined in water (2 mL). These mixtures were stirred for 10 min and left standing for 3 - 4 
weeks for slow solvent evaporation to allow the crystalline complexes form.  
Out of these four combinations, only phthalic acid (PhT) and pyridine-3,5-dicarboxylic acid 
(PyT) yielded X-ray diffraction quality crystals. 
2.6.3. Mono-carboxylic Acid and TBD 
Along with the dicarboxylic acids, the complex formation diversity of TBD was also 
examined in combination with a monocarboxylic acid, glycolic acid. Glycolic acid contains 
only a single carboxylic acid group, but in the crystallization process two equivalents of TBD 
were nevertheless added. The purpose of addition of two equivalents of TBD was to 
investigate the H-bonding property of an alcoholic –OH group in the presence of surplus TBD 
in the complex.    
 
57 
Preparation of Glycolic acid: 2TBD complex (GlT): Glycolic acid (38 mg, 0.5 mmol) and 
TBD (140 mg, 1 mmol) were mixed in water (2 mL) at room temperature. The crystals of GlT 
were obtained after 3-4 weeks.   
 
 
Scheme 2.6.2: Summary of obtained crystalline complexes of TBD with mono- or 
dicarboxylic acids in this study.  
2.7 Single Crystal X-ray Crystallography  
A total of nine crystalline complexes were obtained, then examined under microscope and 
suitable specimens selected for X-ray crystallography. Single crystal X-ray diffraction 
datasets were collected at 105 K on Bruker-ApexII CCD diffractometer (monochromatized 
MoKα radiation, λ = 0.71073Å), which is coupled to an Oxford Cryosystem low-temperature 
device. Data integration reduction and absorption was carried out by SAINT and SADABS, 
respectively.108 All structures were solved by direct methods and refined by full matrix least 
squares based on F2 using SHELXTL.109 Molecular and packing diagrams were generated 
using the program Mercury.110 Detailed data collection, refinements and crystallographic 
information can be found in respective article.  
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2.8 Results and Discussion 
The crystal structure analysis of the nine complexes showed that several of them share some 
common structural properties. This allowed us to classify these nine complexes into the three 
groups below for the convenient descriptions and comparisons.  
 
Scheme 2.8: Classification of the obtained crystalline TBD-carboxylate complexes in the 
present study. 
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2.8.1 Pseudopolymorphic Crystalline Complexes of TBD and BPDA 
The Type I and Type II crystals were obtained from 2:1 and 1:1 mixtures, respectively, from 
TBD and BPDA. Basically these complexes generated a common 2:1:4 (TBD:BPDA:water) 
network building unit (Fig. 2.8.1.1), however their arrangement in the corresponding crystals 
is non-identical, wherein they exist in pseupolymorphic forms.  
Polymorphism: It is the existence of the one chemical substance in more than one crystalline 
form. These exhibit different physical and chemical properties,111-113 whilst 
pseudopolymorphism defines different crystalline forms of a same substance that differ in 
stoichiometry or type of the included solvents.114-116 
Detailed description of these complexes can be found in Publication V. 
 Type I: 
 
Type II: 
 
Figure 2.8.1.1: The pseudopolymorphic Type I and Type II crystals formation from TBD and BPDA. 
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2.8.2 Reproducibility of Type I Complex and Crystal Structure transformation  
The Type I crystals were fragile and very sensitive outside of the water or DMF medium, 
becoming anhydrous within the 30 - 60 min after removed from the mother liquor. When this 
resulting non-crystalline dehydrated complex was redissolved in minimum amount of water (1 
mL) and DMF (2-3 drops), the crystalline Type I form reproduced in 2 weeks. This procedure 
was repeated over two cycles, however, when the similar mixture was processed for the third 
attempt of determining reproducibility, the crystallization process took longer time (6 weeks) 
than usually (1-2 weeks) required for Type I crystals (Fig. 2.8.2). Surprisingly, the obtained 
crystals after third attempt were remarkably stable, even when devoid of any solvent medium. 
The crystal structure unveiled that this stable crystals are in fact Type II crystals, with a 1:1 
(TBD:BPDA) composition. These observations show that the Type I structure has a property 
of structural transformation in solution.  
 
 
Figure 2.8.2: A schematic representation showing the cycles of the Type I crystals reproducibility and 
crystal transformation. 
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2.8.3 Di-anionic complexes from Dicarboxylic acids and TBD 
 
Figure 2.8.3: The dianionic complex forming complexes GuT, PyT, PhT and FuT are renamed and 
referred as the Crystal 1, 2, 3 and 4, respectively, in paper VI. 
 
In the crystalline forms, the glutaric acid, pyridine-3,5-dicarboxylic acid, phthalic acid and 
fumaric acid with TBD were produced the H-bonded dianionic complexes (Fig. 2.8.3). These 
crystals show distinct structural arrangements and include a variety of water assemblies H- 
bonded to the anti-lone pairs of O atoms of the carboxylates.  
Crystal 1 and 2 were found with the incorporated water tapes that are H-bonded to the 
guanidinum-carboxylate adduct. In Crystal 3 TBD did not form ଶଶሺͺሻ motif with the 
carboxylates due to the coulombic repulsions of ortho dianions and steric crowding of TBD, 
nevertheless this complex showed a organized water cluster in the network. Uniquely, crystal 
4 was anhydrous, as the anti-lone pairs of carboxylate O atoms were interacting with weak C-
H donors of TBD molecules.  
Details of these four structures can be found in Publication VI.  
 
2.8.4 Mono-anionic Complexes from TBD and Mono- or Dicarboxylic acids 
 
 
Oxalic acid (OxT) and adipic acid (AdT), in spite the two carboxylic acid groups, form 
monoanionic complexes with TBD, while glycolic acid (GlT) generates a monoanionic 
complex leaving the hydroxyl group to interact with the acceptor carboxylate O atom. The H-
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bonded networks of OxT, AdT and GlT form infinite one-dimensional ribbons. Hence these 
three structures are grouped together and described thoroughly in Publication VII.    
2.9 Conclusions 
This study was a carefully designed and experimentally demonstrated strategy to illustrate the 
constructive use of TBD for the preparation of organic materials. A total of nine crystalline 
complexes were obtained and analyzed by X-ray diffraction methods. Out of these, the 
anticipated interactions of anti-lone pairs of carboxylate O atoms with water molecules were 
observed, and six complexes showed the inclusion of different water networks in their 
crystals. The Type I complex from BPDA and TBD is a very rare example of a purely 
organic framework with a high degree of hydration in the channels.  The crystalline OxT, 
AdT and GlT complexes did not included a reasonable amount of water within the structures, 
but according to their 1D structural properties they can be considered as materials, as gelators 
etc.117 Moreover, as the guanidinium and carboxylate groups are biological functional groups, 
the complexes studied here may provide some insight into specific interactions of similar type 
of molecules. Collectively, the complexes from this study may find various future 
applications as proton conductors, as selective ion channels and as gelators etc.  
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